Modular regenerative hydrothermal reactor and method for mineralization of recalcitrant organic compounds under hydrothermal operating conditions

The modular regenerative hydrothermal reactor addresses corrosion and thermal shock issues in SCWO by using injection/bleed ring devices and a fluid barrier mechanism, ensuring safe and efficient mineralization of persistent organic pollutants.

JP2026538981APending Publication Date: 2026-11-19ピエカシュクリスティーナ
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2026522391
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-10-12
Filing Date
2024-10-11
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing reactor designs for supercritical water oxidation (SCWO) face challenges such as corrosion, blockage, thermal shock, and uncontrolled heat release, which hinder safe and efficient mineralization of persistent organic pollutants like PFAS, leading to safety risks and operational inefficiencies.

Method used

A modular regenerative hydrothermal reactor with an array of injection/bleed ring devices and a fluid barrier mechanism using chemical species as initiators, inhibitors, and insulators, enabling controlled reaction conditions and protection from harsh environments.

Benefits of technology

The reactor design reduces sensitivity to waste feed variations, minimizes thermal shock and corrosion, improves reaction control, and enhances safety by isolating the pressure vessel from high-heat-flux zones, allowing efficient mineralization of recalcitrant organic compounds while reducing maintenance and resource dependency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026538981000001_ABST
    Figure 2026538981000001_ABST
Patent Text Reader

Abstract

Disclosed are a modular regenerative hydrothermal reactor, method, and system for carrying out chemical reactions under harsh conditions. The reactor includes a modular tubular shell with an array of injection / bleeding devices that allow for the carrying out of the chemical reaction and the formation of a protective fluid barrier to isolate the reaction from the reactor.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention relates to modular regenerative hydrothermal reactor systems and methods for carrying out chemical reactions under severe operating conditions, including but not limited to subcritical water reactions and supercritical water reactions. The present invention particularly relates to a reactor design comprising an injection ring device and a bleed ring device for controlled injection and recovery of fluids, as well as a method of protecting reactor components from harsh reaction environments by forming a protective fluid barrier. These systems are applicable to a variety of uses such as treatment of hazardous organic and inorganic wastes or wastewater, energy recovery, and other chemical processes.

[0002] Reference to related applications This application claims priority from U.S. Provisional Patent Application No. 63 / 589,949 filed on October 12, 2023, the entire content of which is incorporated herein by reference. BACKGROUND ART

[0003] The invention disclosed in the present specification relates to reactors and methods for carrying out chemical reactions under severe operating conditions.

[0004] A wide variety of chemical reactions and reactor configurations have been proposed for carrying out chemical reactions under severe conditions. Elements common to various reactions include, but are not limited to, for example, the presence of components that may increase the potential for corrosion such as chlorides and sulfides / sulfates, the presence of scaling components and the accompanying exceeding of equilibrium solubility limits, increased acidity or basicity under operating conditions, high temperature conditions, high pressure conditions, autocatalytic reactions, oxidizing or reducing conditions, reactions that may cause thermal runaway, reactant and / or reaction by-product components considered to have toxicity / hazardousness / carcinogenicity, etc., and / or other conditions known to those skilled in the art.

[0005] Although the present invention is not intended to be limited to specific chemical reactions and / or operating conditions, for convenience, this specification will focus on supercritical hydroxide (SCWO), as this reaction typically involves many of the elements described above. It should be understood that in different embodiments, the methods and apparatus of the present invention may also be applicable to other reactions.

[0006] Beyond the critical point (374°C, 22.1 MPa), water enters a state that is neither liquid nor gaseous. At this point, the thermophysical properties of water change dramatically, creating a unique environment that can accelerate reactions. As the water approaches and exceeds the critical point, the dielectric constant decreases, the solubility of organic and inorganic compounds reverses, and mass transfer becomes unrestricted, thus accelerating reaction kinetics. In supercritical water (i.e., water under conditions of at least 374°C and 22.1 MPa) (SCW), the presence of an oxidizing agent allows for the complete mineralization (i.e., the complete conversion of organic compounds into carbon dioxide, water, and / or salts) of even the most resilient organic compounds, such as perfluoroalkyl and polyfluoroalkyl substances (PFAS).

[0007] While this disclosure is not intended to limit the application of the present invention, PFAS have attracted significant attention in industry due to regulatory requirements, inherent treatment challenges, and potential liability. The U.S. Environmental Protection Agency's (EPA) final maximum pollutant levels, set down to low ppt levels for various compounds, coupled with CERCLA-based classifications, make compliance extremely difficult for water suppliers with limited resources and impose liabilities associated with handling these compounds, as they allow for accountability claims for treatment costs. Such regulatory requirements have impacted many industries, and many treatment processes find it difficult to meet these pollutant levels. However, SCWO has been demonstrated to mineralize the entire group of compounds under appropriate reaction conditions (i.e., typically >600-650°C, >22.1 MPa).

[0008] In addition to its ability to accelerate the decomposition of organic pollutants, SCW enables improved process efficiency and / or energy recovery for power generation, and further enables the recovery of high-value reaction products, and under ideal conditions does not produce NOx, SOx, or other atmospheric emissions. Furthermore, other advantages of using SOW for reactions (i.e., gasification, etc.) are also known to those skilled in the art.

[0009] Over the past several decades, SCW / SCWO has had a wide range of applications, and various reactor configurations have been proposed, including plug-flow reactors (PFRs), tubular reactors, tank reactors, evaporative wall reactors, and other more complex designs discussed in the prior art.

[0010] U.S. Patent No. 5,252,224 (Model I, 1993) discloses a PFR / tubular reactor for oxidizing aqueous mixtures of organic matter under conditions of 21.8 MPa and 374°C or higher. To reduce / mitigate clogging due to salt / solids, the disclosure considers increasing the flow rate of the mixture to prevent sedimentation and mechanically brushing / cleaning the tubular reactor.

[0011] PFR / tubular reactors, such as those manufactured by Modell, offer a common reactor configuration for carrying out reactions due to their high conversion rates and relatively simple design, but they have the following risks: 1) lack of a mechanism to control fouling (which can lead to reduced reaction efficiency due to decreased heat transfer, blockage, and / or corrosion), 2) insufficient control to maintain stable reaction conditions (which can lead to the generation of by-products due to incomplete reactions), and 3) uncontrolled heat release due to exothermic conditions (which can lead to depressurization events).

[0012] In PFRs, as the temperature of organic / inorganic wastewater solutions rises, the equilibrium solubility limits change, potentially leading to the precipitation of multiple components present in the waste (e.g., silica, carbonates, phosphates, metal oxides, etc.). This can hinder heat transfer, leading to reactor blockage and potentially causing depressurization events. In the presence of corrosive species (e.g., chlorides, sulfates, etc.), the walls of tubular reactors are susceptible to fluid-accelerated corrosion (FAC) and / or solid deposit accumulation, which can lead to hideout and / or subsoil corrosion (i.e., concentration of corrosive species in the pores of the deposits, which can reach thousands of times the concentration present in the feed fluid), potentially resulting in stress corrosion cracking (SCC) and / or reactor damage.

[0013] Similarly, fluctuations in organic component concentrations and insufficient control of oxidizer supply can lead to a rapid release of large amounts of heat, potentially resulting in a depressurization event without sufficient warning. For example, high concentrations of organic matter in secondary treated wastewater sludge and / or biosolids can present challenges in controlling heat release associated with the reaction. In 2014, a depressurization event occurred at an Orlando wastewater treatment facility after a tubular SCWO reactor was installed for sludge treatment, causing damage to the system and building, but no injuries occurred (Modell et al., 2008 and Orlando Sentinel, 2014). Therefore, given that the safety of workers, the plant, and the local community is paramount, it is essential to exercise due consideration and caution in the design, manufacture, and operation of SCWO reactors.

[0014] This specification is not intended to comprehensively cover all tubular reactors related to SCWO, but several techniques are disclosed (summarized in Marrone et al., 2004). These include flushing techniques for cooling inorganic components and / or reversing their solubility, the use of additives to promote particle adhesion, eutectic mixtures affecting solubility, density separation, mechanical scraping devices, and other methods that can be used in combination with tubular reactors.

[0015] Conventional and common methods to mitigate issues related to heat dissipation and / or corrosion include the use of nickel-based alloys to improve resistance to harsh conditions. However, as those skilled in the art know, under subcritical conditions, certain components such as chlorides exhibit higher corrosiveness to certain nickel-based alloys than under supercritical conditions, creating unique problems in the preheating process to raise reactor waste to operating conditions. This, coupled with the potential for deposit formation, can easily lead to reactor blockage and / or SCC. In addition, the use of certain nickel-based alloys may limit the tubular reactor's ability to mineralize various recalcitrant organic compounds that require temperatures exceeding the heat resistance limit of the material.

[0016] For example, in the case of some more persistent PFAS sulfonates, such as PFOS, temperatures exceeding >600-650°C may be required to effectively mineralize the compound, and such temperatures may exceed the material limits of certain nickel-based alloys under operating temperature and pressure conditions (i.e., plug-flow reactors made of these nickel-based alloy materials may not be able to safely achieve mineralization of certain compounds to meet prescribed regulatory standards). Many water treatment systems specifically designed for mineralization of persistent organic components such as PFAS or other compounds require high temperatures (>212°F) and high pressures (>2,400 lb / in). 2 Pipe / tubular reactors are used under the following conditions. These reactors are not only susceptible to corrosion and scale / deposit formation, but are also susceptible to thermal shock, especially under oxidizing conditions. This makes it even more difficult to safely and adequately mineralize organic contaminants in complex matrices such as industrial wastewater, landfill leachate, AFFF (firefighting foam), municipal wastewater, foam fractionates, biosolids, membrane concentrates, or aqueous solid slurries contaminated with organic matter such as activated carbon, ion exchange resins, soil, and precipitated solids produced by chemical reactions.

[0017] U.S. Patent No. 6,054,057 (Hazlebeck et al.) discloses a downflow hydrothermal reactor having a vertical configuration, injecting reactants from the top of the reactor, and using a quenching section at the bottom to redissolve salts and reduce blockage. It also discloses a mechanical scraper for removing salt / solids, a corrosion-resistant liner (such as a titanium liner), insulation placed in an annular void between the pressure-holding wall and the liner, and the use of a purge fluid in the annular void to "prevent contaminants from flowing into the void."

[0018] In addition to Hazelbeck et al., various disclosures have been made to date regarding reactors that incorporate elements such as a downflow configuration, injection of reactants from the top of the reactor, a sacrificial liner, and the use of a subcritical quenching section for redissolving salt, as shown in U.S. Patent No. 5,591,415 (Dassel et al.), U.S. Patent Publication No. 2023 / 0398514 (Igor et al.), and International Publication No. 2021 / 204609 (SCFI). While these disclosures advance technical teachings regarding the reduction of blockage and / or corrosion, they have the following problems. 1) Placing the injector nozzle at the top of the reactor increases the likelihood of thermal shock / erosion in the injector due to rapid changes in temperature / heat flux, solubility limits of inorganics / salts, and buoyancy in the reaction zone, and further, if organic / inorganic materials accumulate in the injector nozzle, it may raise safety concerns. 2) If a liner exposed to the reaction is used, inorganic materials (and possibly organic products / reactants) may accumulate in the system, and these components may later detach in very high concentrations, affecting downstream valves and other equipment, increasing system downtime / maintenance burden and reducing reaction efficiency. 3) The liner may wear down due to exposure to corrosive conditions, potentially exposing the pressure vessel to corrosive fluids. 4) The brine in the subcritical region is highly corrosive and may wear down downstream valves and other auxiliary equipment. 5) Control of rapid changes in reactor temperature is limited, raising safety concerns. Reactor control methods based on the use of thermocouples are insufficient for fully understanding rapid temperature changes within the reactor because they can only monitor the temperature at a single discrete point within the system. Therefore, it is extremely difficult (if not impossible) to obtain sufficient warning signs to detect rapid temperature changes, and by the time the thermocouple monitoring the reactor pressure vessel temperature shows a rapid temperature rise, it may already be too late to take corrective or mitigating measures for the control.

[0019] Over the past several decades, the Blue Grass Chemical Agent Destruction Pilot Plant (BGCAPP) has undergone demonstration tests, technical bidding evaluations, detailed designs, and the installation of a downflow hydrothermal reactor to decompose hydrolysates of VX, GB, and H using SCWO. While the reactor was effective in decomposing organic matter, it had numerous operational reliability issues. 100-hour tests using simulated hydrolysates of VX, GB, and H (including sulfates, phosphates, fluorides, and other salts as by-products) revealed: 1) excessive corrosion of the titanium liner and / or thermowell (0.4–1.3 mil / hour), 2) hydrogenation of the liner in some of the simulation tests, and 3) salt accumulation in the reactor after each test (approximately 70–140 pounds per 100-hour test). Furthermore, in engineering-scale tests, the feed nozzle was identified as an "unresolved issue with significant degradation observed" (US Army Chemical Materials Agency, FY03 Technical Evaluation for Chemical Demilitarization, 2003). The various countermeasures proposed by the team included increasing the frequency of liner and / or thermowell replacement, reducing blockage by forming a eutectic mixture of NaCl / Na2SO4 in the reactor (i.e., an attempt to reduce salt accumulation and / or corrosion by adding salt), and diluting drug hydrolysates with energy hydrolysates (i.e., reducing phosphate concentration) (Interim Design Assessment for the BGCAPP, 2005). However, even after moving on to instrument function testing following the completion of system construction, corrosion of the reactor's thermowell and liner (progressing at a rate of approximately 1 mil / hour, particularly more pronounced in the upper part of the reactor) continued to be observed, in addition to many other concerns (National Academies of Sciences, Engineering, and Medicine, 2019).

[0020] U.S. Patents 5,723,045 (Daman) and 5,558,783 (McGuinness) disclose reactor configurations referred to as evaporative wall reactors as means of addressing corrosion and blockage. Both patents disclose a configuration, as a variation of a tubular reactor, that introduces an "evaporative wall" through which supercritical or subcritical water flows through a liner, thereby pushing out salt / solids and reducing the possibility of blockage and / or corrosion. McGuinness uses porous liners, while Daman employs a platelet design with "a structure of multiple stacked thin plates having numerous precisely designed channels that allow water to pass through the wall from the outside." Both designs assume the use of supercritical water passing through the liner or platelet within the annular region, but do not consider the corrosiveness of desalted supercritical water. Furthermore, although both disclosures claim to reduce salt / corrosion, detailed test data and results from Sandia National Laboratory (Haroldsen et al., 1996) and / or BGCAPP (US Army Chemical Materials Agency, FY03 Technical Evaluation for Chemical Demilitarization, 2003) conducted on evaporative wall reactors have reported issues with injector erosion, salt accumulation in the reactor, liner corrosion and / or cracking, and maintaining oxidation stability (i.e., CO / hydrocarbon spikes were observed during testing, which may affect regulatory compliance).

[0021] Other more complex reactor designs include U.S. Patent No. 8,017,089 (Titmas) and U.S. Patent No. 10,851,006 (Cai). Titmas discloses a method for reducing the possibility of contact between salt / solids and the vessel by forming a film of supercritical water (demineralized water) between the vessel and the reactants, but does not directly address the removal of accumulated salt / solids that are recycled within the reactor. Furthermore, the use of supercritical water means that the salts remain insoluble, which can result in them adhering to the reactor walls and promoting corrosion. Although the patent acknowledges the erosive / corrosive nature of demineralized water, it employs sacrificial liners as a countermeasure, which suggests that this would entail an additional maintenance burden in complex, custom reactor designs. Cai discloses a tubular reactor with two tubular outlets within a common reaction chamber, each outlet positioned at a vertical height corresponding to either supercritical or subcritical temperature conditions. While the disclosure acknowledges the reversal of the solubility limit in the subcritical zone, salt may settle at the supercritical side outlet, potentially causing blockages during the discharge of treated effluent. Furthermore, the placement of the waste and oxidizer inlets at the bottom of the reaction chamber (in brine) may hinder mass transfer and heat transfer, potentially leading to the formation of unoxidized reaction byproducts. In addition, this type of design requires custom-designed reactors tailored to each feedstock, and their complex structure inherently carries risks related to resource procurement, material sourcing, manufacturing, product / project development / delivery, and / or long-term sustainable operation and maintenance. [Overview of the Initiative] [Problems that the invention aims to solve]

[0022] Unfortunately, none of these prior art documents reduce or mitigate many of the challenges known to those skilled in the art, and there is still a need for reactor designs capable of handling the harsh operating conditions of SCWO. This is a factor hindering its development and commercialization, despite its many advantages as one of the few effective treatment technologies for decomposing persistent organic pollutants. MEANS FOR SOLVING THE PROBLEMS

[0023] Summary of the Invention Disclosed herein are a modular regenerative hydrothermal reactor and a method thereof as a solution for carrying out chemical reactions involving severe operating conditions. Specifically, disclosed are a reactor and a method featuring a modular shell comprising an array of injection / bleed ring devices configured to perform radial injection, tangential injection, and bleed of reactants, as well as regeneration of a fluid barrier mechanism that includes chemical species functioning as initiators, inhibitors, and / or insulators. The fluid barrier mechanism isolates the chemical reaction from the reactor body, and the controlled response and / or transition of the chemical reaction in accordance with changes in the operating conditions of the reactor is enabled by the devices operating in fluid communication with one another.

[0024] As an embodiment of the present invention, there are disclosed a reactor and a method related to application under SCWO and subcritical conditions for mineralizing persistent organic compounds such as PFAS in the presence of inorganic compounds. These embodiments provide potential advantages over the prior art, for example, as follows. 1) Reduced sensitivity to waste feed characteristics. 2) Reduction / elimination of thermal shock / erosion at the reactant injector and loss of reaction heat, by a radial injection design combined with a protective fluid barrier layer containing chemical species functioning as an initiator and / or an insulator. 3) Improved controllability of reaction and neutralization by the array of injection / bleed ring devices and a multi-layer redundant configuration prepared for potential failures. 4) Reduction of corrosion and / or thermal damage to the liner and / or pressure vessel by a fluid blend containing a combination of chemical species functioning as initiators, inhibitors, and / or insulators. 5) Improved controllability in the event of an unexpected rise in the temperature of the reaction zone, due to self-response resulting from the combination of chemical and thermophysical properties of the fluid barrier. 6) Reduction of wear on downstream valves and other accessory equipment caused by accumulated inorganic compounds, through continuous bleed and / or regeneration of the fluid barrier. 7) Reduction in the consumption of raw material chemical species used as initiators, inhibitors and / or insulating agents by regeneration and / or recirculation of fluid barriers. 8) The simplified modular design improves the following: a) Applicable range of reactor capacity / turndown capacity, b) Scalability of production and / or product / project delivery to respond quickly to increased demand, c) Product quality through manufacturing consistency, d) Easily accessible maintenance work, e) Prompt availability of spare parts, and / or f) Safety due to the ease of localizing potential failures through modular design. 9) The design takes into account the requirements for supporting end users over the long term in an evolving market environment, and by not requiring custom / complex designs and being independent of specific material suppliers, technology suppliers, and / or manufacturers, it reduces long-term risks caused by fluctuations in resource supply. 10) By designing a combination of chemical species that function as initiators, inhibitors, and insulators to isolate the pressure vessel wall from the high-heat-flux reaction zone, the following can be achieved: a) Conducting high-temperature reactions to improve reaction efficiency, b) Shortening of dwell time, c) Improvement of processing capacity, d) A rapid and controlled response to maintain the pressure vessel at a low temperature to satisfy ASME Section VIII, Div1 and / or ASME Power Piping Code B31.1, and / or e) Use of commercially available alloys such as stainless steel instead of conventional nickel-based alloys, which have high costs and lead times.

[0025] Embodiments of the present invention will be described in further detail below. Embodiments of the present invention include a modular regenerative hydrothermal reactor apparatus, a method for protecting against harsh reaction conditions, and a system for subcritical and SCWO applications using both the reactor apparatus and the method.

[0026] Several embodiments provide modular, regenerative hydrothermal reactors and methods for SCWO and mineralization of persistent organic compounds such as PFAS in the presence of inorganic compounds. These reactors and methods employ a radial injection design combined with a protective fluid barrier layer containing chemical species that function as initiators and / or insulators, offering several advantages over the prior art, including reduced sensitivity to variations in waste supply characteristics, as well as elimination of thermal shock, reactant injector erosion, and reaction heat loss. Furthermore, the reactors according to these embodiments achieve improved controllability of the reaction and neutralization through the arrangement of injection / bleeding devices. In some embodiments, multiple redundant configurations are provided to ensure reliability in the event of failure. By using a fluid blend containing chemical species that function as initiators, inhibitors, and / or insulators, corrosion and thermal damage to the liner and pressure vessel are reduced. In addition, these systems improve controllability in the event of an unexpected rise in the temperature of the reaction zone through self-response based on the chemical and thermophysical properties of the fluid barrier.

[0027] In embodiments of the present invention, wear of downstream valves and other components due to accumulated inorganic compounds is minimized by continuous bleeding and regeneration of the fluid barrier, and the consumption of raw material chemicals is reduced by the regeneration and recirculation of the fluid barrier. The simplified modular design of these reactor embodiments improves reactor capacity and turndown capability, scalability, product quality, maintenance, and availability of spare parts, while also improving safety by enabling the localization of potential failures. Furthermore, these designs reduce risks due to fluctuations in resource supply by avoiding dependence on specific material or technology suppliers, and enable the response to long-term user needs. The reactor embodiments feature a configuration that isolates the pressure vessel wall from the high-temperature reaction zone by a combination of chemical species that function as initiators, inhibitors, and insulators, thereby enabling reactions to be carried out at high temperatures, reducing residence times, improving processing capacity, and providing a rapid and controlled response to maintain the pressure vessel at low temperatures, satisfying the requirements of ASME Section VIII, Div1 and ASME Power Piping Code B31.1. More importantly, embodiments of the present invention enable the use of commercially available alloys such as stainless steel instead of conventionally used, expensive nickel-based alloys with long procurement lead times.

[0028] Several exemplary embodiments of the present invention Embodiments of the present invention provide a modular hydrothermal reactor (sometimes also referred to as a “downflow liquid film” reactor (FFR)) and related methods, characterized in that the reactor is vertically oriented and at least one fluid barrier layer includes a downflow configuration. The FFR according to the present invention comprises a configuration that generates multiple liquid films (protective fluids) formed by the controlled injection of reagents into the reactor. The reactor design according to the present invention protects the pressure vessel from salt / deposit buildup and provides a thermal barrier and corrosion barrier. The protective fluid and / or downflow liquid film perform functions such as reducing / cleaning salt / deposits, protecting from temperature gradients, allowing the use of general-purpose metal materials, improving the flexibility of the reactor through a modular design, and improving the decomposition and removal efficiency (DRE) of organic contaminants.

[0029] In some embodiments, the hydrothermal reactor configuration can be vertically oriented, but it may also be horizontally oriented. Multiple reactors can be operated in parallel or in series, depending on the supply and operating characteristics. One or more reactors can be operated in either continuous or batch mode. In further embodiments, multiple reactors can be configured in parallel and multiple smaller reactors can be combined to ensure a wider turndown capacity and provide system redundancy.

[0030] Multiple operating conditions or specific parameters may influence the operating mode by which the modular regenerative hydrothermal reactor of the present invention effectively and safely carries out chemical reactions. These parameters include, but are not limited to, temperature, pressure, flow rate, residence time, concentration, and the types of reactants and reagents used. The operating conditions may also include the physical state of the fluid (e.g., subcritical or supercritical water state), the use of auxiliary heating means (e.g., co-fuel or external heater), and the configuration of the reactor module (e.g., vertical or horizontal orientation, series or parallel arrangement of one or more reactors). The selection of operating conditions depends on factors such as supply characteristics, desired reaction targets, selection of reactants / reagents, and reactor design, including the constituent materials of the liner and containment vessel. For example, one embodiment of the reactor may be operated under supercritical hydro-oxidation conditions with a temperature above 374°C and a pressure above 22.1 MPa to mineralize recalcitrant organic compounds, while another embodiment may be operated under subcritical conditions for similar and / or different processing purposes. In addition, different modules within the reactor system may be maintained under different operating conditions (e.g., transition from oxidation and / or reduction reactions to the neutralization process) to optimize performance, adapt to variations in supply characteristics, and improve overall efficiency and safety.

[0031] Some embodiments of the hydrothermal reactor according to the present invention can be operated under conditions either above or below the supercritical point of water. In other embodiments, the reactor can be operated under supercritical water oxidation conditions (e.g., temperature >374°C, pressure >22.1 MPa), but low-pressure / low-temperature conditions, low-pressure / high-temperature conditions, high-pressure compressed water conditions, steam conditions, wet air oxidation (WAO) conditions, hydrothermal oxidation conditions, or other similar conditions are also applicable. Furthermore, in some embodiments, the entire hydrothermal reactor system can be operated under multiple operating conditions (e.g., at multiple locations within the hydrothermal reactor system). Heating of the reactor may be performed by either an auxiliary fuel / common fuel (e.g., IPA) or an external electric heater. For example, in applications supplying wastewater containing persistent organic pollutants, the operating conditions depend on the characteristics of the wastewater, the choice of reagents, and the treatment objectives.

[0032] In some embodiments, various reagents and / or reactants are used within the reactor system to optimize performance and ensure effective wastewater treatment. These reagents and reactants perform multiple functions, including, among others, facilitating the removal of persistent organic compounds, inhibiting corrosion, and controlling unwanted deposits. The selection of appropriate reagents depends on the specific operating conditions of the reactor and the characteristics of the wastewater being treated. Therefore, flexibility in reagent selection enables a more adaptable and efficient system capable of handling diverse wastewater streams.

[0033] In some embodiments, one or more of the reagents / reactants exemplified below may be used upstream, downstream, and / or internally within the reactor system to perform functions such as removing / accelerating the mineralization of persistent organic compounds and / or catalyzing them, inhibiting corrosion, providing cooling, reducing deposits, controlling reactions, suppressing by-products, treating emissions, intentionally forming deposits, supplying heat, and / or other functions.The composition (recipe) of reagents / reactants may include, but is not limited to, one or more of the following: oxidizing agents (compressed air, oxygen, hydrogen peroxide, ozone, etc.), pH adjusters (acetic acid, sodium hydroxide, etc.), alcohols (ethanol, methanol, etc.), subcritical or supercritical water, other supercritical fluids, steam, co-fuels (common fuels, IPA, hydrogen, biogas, biodiesel, etc.), helium, hydrogen, nitrogen, ammonia, urea, surfactants (amphoteric, anionic, cationic, nonionic), morpholine, cyclohexylamine, diethylaminoethanol, ethanolamines, monoethanolamine, methylamines, ethylamines, 3-methoxypropylamine, 2-aminoethoxyethanol, glycol, glycolic acid, diethylhydroxylamine (hydroxylamines), oleylpropylenediamine, orthophosphates, polyphosphates, potassium pyrophosphate, sodium tripolyphosphate, sodium hexametaphosphate, superoxide, phosphoric acid, non-NFP Compounds, peracetic acid, zinc compounds, triazole compounds, dihydrogen phosphates or trisodium phosphates, dichloromethane, permanganates, potassium ironate, hydrazine, carbohydrazides, phosphonates, aminotris(methylenephosphonic acid), 1-hydroxyethylidene-1,1-diphosphonic acid, phosphonobutane-1,2,4-tricarboxylic acid, polyaminopolyethermethylenephosphonic acid, acrylic acid and allylhydroxypropylsulfonic acid ethers, polyepoxysuccinic acid, ammonium peroxydisulfate, terpolymers of acrylic acid, 2-acrylamide-2-methylpropylsulfonic acid, t-butylacrylamide, ammonium acetate, fluorescein two-phase solvents, molybdenum compounds, iron compounds, oxygen scavenging compounds, general cleaning-in-place (CIP) reagents, or compounds that promote oxidation reactions, passivation protection reactions, extractions, and by-product formation inhibition reactions that improve the DRE of organic compounds, reactants produced by electrochemical means, and other reactions. Please understand that the specific composition of the reagents depends on the chemical reaction and the operating conditions of the reactor / system.Methods and examples of hydrothermal reactors for the mineralization of persistent organic compounds in the presence of inorganic compounds are disclosed in Section 3, which uses SCWO, and in Section 4, which uses subcritical conditions.

[0034] Schematic diagrams of general process flows according to several embodiments of the present invention are shown in Figures 12A, 12B, and 12C for supercritical and subcritical conditions. In these embodiments, the waste feed stream (e.g., organic contaminated wastewater), reactants / reagents, and (if necessary) co-fuel are preheated before injection, pressurized to reactor operating conditions, injected into the reactor, and maintained at appropriate residence times and operating conditions for the reaction to proceed. Brine and / or solid components, which are effluents from the reactor, are treated (if present), and reactor effluents (i.e., distillates and / or brine) may be appropriately quenched and depressurized (i.e., gas-liquid separation) for subsequent treatment or discharge. Preheating of organic contaminated wastewater is determined depending on the specific feed characteristics and may or may not require the addition of reagents such as pH adjusters to suppress precipitate formation in order to improve transportability. Auxiliary fuel may be used during startup or when temperature maintenance is required, which may depend on the reactor operating conditions and wastewater characteristics. Depending on the reactor operating conditions and wastewater characteristics, reagents may be added before depressurization during the reactor quenching process. Depending on the reactor operating conditions and wastewater characteristics, the gas released during the gas-liquid separation process is discharged after scrubbing and monitoring. Depending on the wastewater supply characteristics, salt may be recovered at each stage of the reactor and / or process. Typical system components include a supply system, injector, pump, reactor, solids treatment device, quenching device, depressurization device, gas-liquid separation device, and heat exchanger.

[0035] As shown in Figures 13A and 13B, the reactor of the present invention may comprise at least two regions, namely a central reaction zone and at least one film-forming zone (also referred herein as a “concentric protective zone” or “protective fluid barrier”). In some embodiments, a protective liner may be positioned between these two zones. In other embodiments, as shown in Figure 13B, a plurality of film-forming zones may be provided circumferentially arranged around the central reaction zone, with one or more liners positioned between each zone. These liners may be porous or non-porous (solid) and are selected based on the operating conditions of the adjacent zones and the operating conditions of the reactor.

[0036] In some embodiments, the protective fluid injection port is configured to form one or more film-forming zones to protect the pressure vessel by a concentration gradient and / or temperature gradient, which are also referred to herein as “flowing film,” and / or “concentric protective zones,” and / or “protective fluid barriers.” The specific reagents and operating conditions selected for the concentric protective zones depend on the characteristics of the organic wastewater feedstock. In embodiments in which a protective liner is inserted, the injection ports may be located on both sides of the liner, thereby forming a first film-forming zone on the outer diameter side (e.g., between the liner and the pressure vessel) and a second film-forming zone on the inner diameter side of the liner (e.g., between the liner and the reaction zone). See, for example, Figure 13B. When a protective liner is present, the first film-forming zone (zone 1) may provide thermal insulation to maintain the reactor temperature, contribute to maintaining the system pressure, and further provide protection for the outer pressure vessel. In some embodiments, the film-forming zones function by utilizing the pressure difference across the liner to drive inward flow to a second film-forming zone (zone 2), thereby providing auxiliary thermal / deposit / corrosion protection, diffusing reactants from film-forming zone 1 to film-forming zone 2, and further providing a purging function to prevent backflow and the entry of corrosive or organic contaminants into the outer annular region, in addition to enabling the system to transition to a layup state when stopped under the blanket. If a protective liner is present, film-forming zone 2 can wash away salt / deposits from the liner surface, providing thermal / corrosion protection for the liner, and protecting the outer pressure vessel. In some embodiments, contaminants and / or reactants and / or reaction by-products may diffuse into either film-forming zone. In some embodiments, protective fluid discharge ports are configured to bleed fluid from the film-forming zones (i.e., concentric protective zones) to purge and treat organic and / or inorganic compounds diffused within the zones, and further regenerate the protective fluid barrier.

[0037] In some embodiments, a primary reactant injector is configured to inject reactants into a central reaction zone where the chemical reaction takes place. The reactor may be configured to include a primary reactant injector consisting of a longitudinal reactant injector surrounded by protective fluid injection ports, as shown in Figure 14A. In some embodiments, the reactor may further be configured to include a primary reactant injector consisting of radial injectors via a modular film-forming injection / bleed ring incorporated between each section, as shown in Figure 14B. The modular ring may be configured to include discharge ports that allow for bleed discharge from the film-forming zone. In the embodiment shown in Figure 14B, the modular injection ring forms a protective film-forming zone and facilitates the reaction within the reaction zone. The modular ring is also configured to include discharge ports that allow for bleed discharge from the protective film-forming zone. The injection ring may be configured to improve the performance of the reactor and may further provide corrosion protection and a thermal barrier.

[0038] As shown in Figures 14B and 11, the flowing liquid film may flow from the first injection ring Nx to the second injection ring Nx+1 and may be configured to wash away salt / deposits from the pressure vessel or liner, take in reactants to promote the mineralization of organic compounds or other chemical reactions, assist in the passivation of the pressure vessel, provide cooling, enable the transition of the system to a layup state, and / or switch to CIP mode.

[0039] In some embodiments, the upper layer of the injection ring Nx may be configured to recover the spent liquid film supplied from the injection ring Nx-1, and to ensure that no by-products resulting from incomplete mineralization of organic matter or other reactions remain, and in particular to recover salts. In some embodiments, a portion of the spent liquid film may be withdrawn from each module section and recycled back into the reactor influent for processing and / or regenerated for reuse. As shown in Figure 14C, the spent liquid film may be withdrawn from each module section and transported to a common processing module for fluid recovery (see, for example, Figure 14D).

[0040] Along the length of the reactor, each injection ring may be configured to operate under different conditions and may receive a supply of film-forming and catalytic reagents. Depending on the reactor operating conditions, the reagents may be preheated and pressurized before injection. Examples of modular film-forming injection rings are shown in Figures 1-3.

[0041] Embodiments of the reactor of the present invention may include a primary longitudinal reactant injector (described in more detail below), a bleed discharge and injection ring (described in more detail below), a tubular shell (e.g., a pressure vessel), a protective liner (optional), a solids section, and a neutralization / quenching section. The reactor may or may not include a primary longitudinal reactant injector, as it is configured to simply pump contaminated wastewater into the reactor and allows for the acceleration of the reaction and the formation of a protective film by the injection ring. Alternatively, the reactor may have a primary longitudinal reactant injector but no injection ring (e.g., a single injection point), in which case a liquid film-forming zone is formed by a protective fluid injection port surrounding the longitudinal reactant injector. In some embodiments, the reactor may include a primary longitudinal reactant injector comprising multiple modular sections including an injection / bleed discharge ring. The primary longitudinal reactant injector may be connected to the first module section of the reactor by flanges or other means, or similar connecting means suitable for a pressure vessel, as shown in Figure 3G. Each modular reactor section and each injection ring may also be connected by flanges. Sacrificial liners may be used to provide additional corrosion / thermal protection for highly corrosive feeds. Each section may be configured as self-contained, equipped with supply systems for liquid film-forming reagents, catalyst reagents, etc.

[0042] Figures 13A and 13B show simplified bird's-eye views of the liquid film-forming zone from above an exemplary ring, illustrating embodiments with a protective liner (Figure 13B) and embodiments without a protective liner (Figure 13A), respectively. For highly corrosive feedstocks, it is preferable to provide a liner to isolate the reaction zone from the pressure vessel. The liner may consist of a replaceable solid or porous concentric material. The liner may be placed within the pressure vessel and secured in place by an injection ring which may have one or more grooves for receiving the liner.

[0043] In some embodiments, the reactor configuration and module sections may depend on the reactor operating conditions and wastewater characteristics. For example, but not limited to, a tubular reactor may include multiple bleed discharge / injection rings or attemperers strategically placed within the process to improve system safety, reduce salt buildup / blockage / fouling, and control or improve heat distribution.

[0044] The injection ring and bleed discharge ring may be incorporated within the same body and may include a radial injection channel for reactants, at least one tangential injection channel for a protective fluid barrier located near the radial injection channel (e.g., below), and a tangential collection channel (e.g., a bleed collector) located near the radial injection channel (e.g., above) and configured to receive a protective fluid barrier corresponding to the injection of the protective fluid barrier from a separate injection / bleed discharge ring device (e.g., located directly above).

[0045] In vertical embodiments having one liquid film-forming zone and one reaction zone, the radial reactant injection channel may include a primary reactant injection manifold positioned in the midplane of the main body. This primary reactant injection manifold communicates with a plurality of primary reactant injection nozzles circumferentially arranged along the inner circumference of the ring, which are configured to inject reactants radially into the reaction zone. Below these embodiments, a primary protective fluid injection manifold is provided, having a circumferential channel and communicating with a plurality of longitudinal injectors, which is configured to inject fluid axially into the primary concentric protective zone. Similarly, above these embodiments, a primary protective fluid barrier recovery manifold is provided, which communicates with a plurality of collection conduits aligned with the longitudinal injectors of the primary protective fluid barrier injection manifold, and is configured to recover used liquid film (e.g., reaction by-products such as reagents, salts, or residues) from the upper injection / bleed discharge ring device and module section. Each zone within the reactor system may be provided with multiple injectors communicating with a manifold and multiple collectors communicating with a separate manifold. These injectors and collectors may be arranged in an alignment so that the descending liquid film (e.g., protective reagents, reaction by-products, salts, or residues) flowing down from the upstream stage can be collected by the multiple collectors.

[0046] In embodiments having multiple liquid film-forming zones, a secondary protective fluid injection manifold and a corresponding recovery manifold may be provided, which may include multiple injectors adjacent to the longitudinal injector of the primary protective fluid injection manifold. Between the primary protective fluid injector and the secondary protective fluid injector, one or more grooves may be provided on both the upper and lower surfaces for holding one or more liners separating each zone. Between the primary protective fluid collector and the secondary protective fluid collector, one or more grooves may also be provided on both the upper and lower surfaces for holding one or more liners separating each zone.

[0047] In some vertical embodiments, multiple reactor sections may be provided, with multiple film-forming injection and bleed discharge rings positioned between each section. These rings may extend along the length of the reactor, as shown in the exemplary embodiments of Figures 4, 5, and 6. In such embodiments, the number and spacing of the injection rings may be defined by the reactor operating conditions, wastewater characteristics, materials, and temperature / concentration gradient profile. The injection rings may comprise a collection of supply lines (e.g., manifolds) for transporting reactants, film-forming reagents, and optional catalysts to multiple perforated injection ports (e.g., holes, nozzles, etc.) arranged circumferentially around the reactor. The bleed discharge rings may comprise a collection of discharge ports corresponding to the arrangement of supply lines, and the collection of discharge ports may be configured to collect the spent film. Depending on the reactor operating conditions, one or more grooves may be provided in the rings for holding in place one or more protective liners positioned between the pressure vessel and the reaction zone. The liners may be solid or porous and may be configured based on the reactor operating conditions.

[0048] In embodiments of the reactor, perforated injection ports (holes) may be arranged circumferentially along the inner ring and may be configured to direct the reagent flow inward toward the reaction zone, thereby initiating and / or catalyzing the reaction. Along the underside of these rings, the reagent flows down along the length of the reactor, thereby forming a liquid film-forming zone. On the upper surface of the injection rings, the used liquid film and reagents are collected.

[0049] In some embodiments, the primary reactant injection port is configured to influence the reaction by injecting reagents to achieve a more uniform reaction rate or to improve the DRE of organic compounds. A mixture of multiple reagents can be injected to promote the mineralization of organic compounds, improve the DRE, catalyze the reaction, or perform online CIP (clean-in-place washing). In such embodiments, the port is configured to inject reagents into the reaction zone under conditions exceeding stoichiometric ratios under appropriate monitoring, and it is possible to switch between supplying primary reactants to promote the mineralization of organic compounds and performing online CIP, depending on the characteristics of the feed containing organic contaminants and the operating conditions of the reactor. In alternative embodiments, scavenger reagents or reagents that inhibit the reaction can also be injected into the reaction zone, thereby improving controllability over the operating conditions of the reactor.

[0050] In some single-injector configuration embodiments, the reactor of the present invention may be configured to have only a primary longitudinal injector for treating organic contaminated wastewater. In the reaction zone, organic contaminated wastewater, a reaction mixture (e.g., oxidizer / SCW under supercritical conditions), and co-fuel (if necessary) may be injected directly through the primary longitudinal injector and finely dispersed at the top of the reactor, along with appropriate cooling to protect the injector (see Figure 17). In such embodiments, the finely dispersed mixture is crucial to increase the reaction surface area and promote the complete mineralization of the organic matter. The injector may have an appropriate cooling mechanism or liner to protect it from corrosion or thermal shock. A temperature gradient resulting from a single injection point is formed along the length of the reactor. In the film-forming zone (e.g., the outer periphery of the primary injector), one or more reagents may be injected through injection ports. For example, if the reactor is operated under supercritical conditions and a solid protective liner is provided, film-forming zone 1 may consist of compressed air, and film-forming zone 2 may consist of high-temperature subcritical water for washing the liner.

[0051] Method 2: Multiple injection points (primary injector + injection ring)

[0052] In some multi-injector configurations, multiple injection points may be provided. In these embodiments, primary injection is performed as described above, and then additional injections may be performed at multiple locations along the length of the reactor. In these embodiments, the injection ring allows for control of the reaction and improves thermal / corrosion protection (see Figures 18 and 19). For example, under supercritical operating conditions, the ID port of the injection ring may consist of co-fuel and SCW / oxidant, and may have a two-point injection option for injecting oxygen scavenger at strategic locations within the reactor. In such configurations, the reactor may have a radially uniform and high temperature distribution throughout the reaction zone along its longitudinal direction to improve DRE. The injection port for liquid film formation may contain high-temperature subcritical water for cleaning the liner. In embodiments with multiple injection points for reactants, reactants may be supplied under different reactant conditions (e.g., different reagents to promote mineralization, switching operation with CIP cycles, various reagents to catalyze the reaction, etc.). Each module section may have its own independent line for injected reactants.

[0053] Embodiments of the Invention One embodiment of the present invention provides a method for controlling a chemical reaction and protecting the inner wall of a chemical reactor. The method involves forming a central reaction zone by radially injecting reagents toward the central axis of the reactor using an array of individual devices, thereby initiating, maintaining, and transitioning the chemical reaction. These methods include generating a protective fluid barrier around the reaction zone by tangentially injecting reagents, thereby forming at least one concentric protective zone that shields the inner wall of the reactor from the reaction conditions. The fluid barrier is regenerated by bleeding out the reagents and / or reaction by-products, adjusting the barrier as needed, and recirculating it into the reactor. These methods are carried out in fluid communication with a chemical reactor monitoring system, which allows for adjustment of reactor conditions by feedback-controlling the flow rates of reagents and by-products. The method is applicable to a variety of chemical reactions, including autocatalytic reactions, oxidation reactions, and reduction reactions, and its operating conditions range from high to low pH and can accommodate conditions exceeding the solubility limits of specific components.

[0054] In some of these embodiments, a central reaction zone, which may contain a catalyst, is operated at a temperature of at least 100°C and a pressure range of 50 psi to 2,400 psi or higher. This zone may contain organic compounds, including organic halogen compounds, or inorganic compounds, such as chlorides, sulfates, silica, or other components. A protective fluid barrier can consist of reactants / reagents that provide protection against thermal, chemical, or corrosive elements, and this barrier can be modified by thermal, chemical, or physical treatment processes. Specific applications of these methods include the treatment of PFAS such as PFOA and PFOS, which are carried out under supercritical water conditions, where the reactor is operated at a temperature of at least 374°C and a pressure exceeding 22.1 MPa. These methods enable supercritical water oxidation (SCWO) using various feedstocks such as industrial wastewater, landfill leachate, and aqueous film-forming foam (AFFF), along with oxidizing agents such as hydrogen peroxide, oxygen, or air.

[0055] In other embodiments of the present invention, methods are provided for auxiliaryly controlling the reaction profile by radially injecting a mitigating agent such as carbon dioxide or nitrogen, or for adjusting the reaction kinetics by introducing initiators, inhibitors, and oxidizers for excess combustion. In some configurations, a concentric protective zone surrounding the central reaction zone may consist of a subcritical fluid, a reaction inhibitor, or a thermoregulator, which are maintained in a separate fluid chamber. In other embodiments, the concentric protective zone may contain a fluid mixture of supercritical water, nitrogen, or a molten salt for thermal and chemical protection. In addition to controlling the reaction behavior, these methods include the use of a feedback system that monitors reactor conditions such as temperature, pH, oxidation-reduction potential (ORP), and pressure, which adjusts the fluid injection and bleed discharge rates to maintain optimal operation. Bleed discharge from the central reaction zone and protective zone allows for heat recovery, by-product recovery, or cleaning of reactor components. The method may employ a configuration in which the protective zone is separated from the central reaction zone using a solid or porous liner made of a material having low thermal conductivity (e.g., less than 1 W / (m*K)).

[0056] In yet another embodiment of the present invention, a modular hydrothermal reactor is provided that includes a cylindrical pressure vessel equipped with an injection / bleed ring device for radial and tangential fluid injection and bleed discharge, and is equipped with a real-time monitoring and feedback system for controlling reactor conditions. These modular reactors can be operated in continuous flow mode or batch mode and are applicable to the treatment of a wide range of industrial and municipal wastewater under extreme operating conditions, including SCWO. Systems comprising these reactors may be integrated with heat exchangers, depressurization devices, and systems for recovering treated effluent and by-products. The modular reactors are suitable for both portable and stationary applications and can be controlled by programmable logic controllers (PLCs), distributed control systems (DCSs), SCADA systems, and even machine learning or AI-based control schemes.

[0057] Further aspects and embodiments will be apparent to those skilled in the art based on the description and disclosure herein.

[0058] Therefore, the object of the present invention is to provide advanced means for handling highly reactive chemical reactions in a modular reactor system, thereby achieving operational flexibility and scalability for a variety of applications.

[0059] Furthermore, an objective of the present invention is to improve the safety, reaction efficiency, and controllability of the system by isolating the chemical reaction from the reactor wall, while also enabling the use of more readily available and cost-effective materials.

[0060] Another objective of the present invention is to provide a modular reactor system that uses SCWO to remove and / or decompose organic contaminants such as PFAS from contaminated waste and / or wastewater.

[0061] Another objective of the present invention is to provide a modular reactor system for removing and / or decomposing organic pollutants such as PFAS in waste and / or wastewater, which can be constructed from low-cost, readily available commercial materials such as stainless steel.

[0062] Another objective of the present invention is to provide a modular reactor system that reduces corrosion of the reactant injector, liner, and / or reactor wall.

[0063] Another object of the present invention is to provide a modular reactor system that reduces thermal damage to the reactant injector, liner, and / or reactor wall.

[0064] Another objective of the present invention is to provide a modular reactor system with improved controllability over reactions and / or reaction neutralization.

[0065] Another objective of the present invention is to provide a modular reactor system that reduces the loss of reaction heat.

[0066] Another object of the present invention is to provide a modular reactor system that reduces the accumulation of inorganic materials and / or reaction by-products.

[0067] Another object of the present invention is to provide a modular reactor system that reduces the reactor's sensitivity to waste supply characteristics.

[0068] Another object of the present invention is to provide a modular reactor system that has a simple design and improves scalability in terms of consistency in production, product supply, and manufacturing.

[0069] Another objective of the present invention is to provide a modular reactor system with multiple layers of redundancy to prepare for potential failures.

[0070] The above-mentioned objectives, advantages, and features of the present invention, as well as its configuration and mode of operation, will become more apparent by reading the following detailed description with reference to the accompanying drawings. Similar elements are denoted by the same reference numerals throughout the drawings described herein. Furthermore, the benefits and other advantages of the present invention will be readily apparent from the detailed description of preferred embodiments. [Brief explanation of the drawing]

[0071] [Figure 1] This is a perspective view of an injection / bleeding ring according to one embodiment of the present invention.

[0072] [Figure 2] This is a top view of the injection / bleeding ring according to one embodiment of the present invention.

[0073] [Figure 3] This is a side view of the injection / bleeding ring according to one embodiment of the present invention.

[0074] [Figure 3A] This is a longitudinal cross-sectional side view along the line 3A-3A in Figure 3, according to one embodiment of the present invention.

[0075] [Figure 3B] This is a cross-sectional top view along the line 3B-3B in Figure 3, according to one embodiment of the present invention.

[0076] [Figure 3C] This is a side view of an alternative embodiment of injection / bleeding according to one embodiment of the present invention.

[0077] [Figure 3D] This is a cross-sectional side view along the line 3D-3D in Figure 3C, according to one embodiment of the present invention.

[0078] [Figure 3E] This is a top view of Figure 3C along the line 3E-3E in Figure 3C, according to one embodiment of the present invention.

[0079] [Figure 3F] This is a top view of Figure 3C along the line 3F-3F in Figure 3C, according to one embodiment of the present invention.

[0080] [Figure 3G] This is an exploded view of a clamp and / or flange connection system according to one embodiment of the present invention.

[0081] [Figure 3H] This is a side view of yet another alternative embodiment of injection / bleeding according to one embodiment of the present invention.

[0082] [Figure 4] This is an enlarged cross-sectional view of the injection / bleeding ring according to one embodiment of the present invention.

[0083] [Figure 5] This is a cross-sectional side view of a hydrothermal reactor along the cross-sectional line in Figure 8B, according to one embodiment of the present invention.

[0084] [Figure 6]This is a cross-sectional side view of a hydrothermal reactor along the cross-sectional line in Figure 8A, according to one embodiment of the present invention.

[0085] [Figure 7] This is a side view of a hydrothermal reactor according to one embodiment of the present invention.

[0086] [Figure 8A] This is a top view of a hydrothermal reactor according to one embodiment of the present invention.

[0087] [Figure 8B] This is a top view of a hydrothermal reactor according to one embodiment of the present invention.

[0088] [Figure 9] This is a schematic diagram of the radial flow in a concentric protective zone surrounding a central reaction zone according to one embodiment of the present invention.

[0089] [Figure 10] This is a schematic diagram of the radial and axial flow of a concentric protective zone surrounding the central reaction zone, resulting from the arrangement of injection / bleed ring devices in a hydrothermal reactor, according to one embodiment of the present invention.

[0090] [Figure 11] This is a schematic diagram of the radial and axial flow of a concentric protective zone surrounding the central reaction zone, resulting from the arrangement of injection / bleed ring devices in a hydrothermal reactor, according to one embodiment of the present invention.

[0091] [Figure 12A] This is a simplified process flow diagram of one embodiment of a hydrothermal reactor and method according to one embodiment of the present invention.

[0092] [Figure 12B] This is a process flow diagram of a hydrothermal reactor according to one embodiment of a reactor and method for subcritical applications.

[0093] [Figure 12C] This is a process flow diagram of a hydrothermal reactor according to one embodiment of a reactor and method for SCWO applications.

[0094] [Figure 13A] This is a cross-sectional top view of the reaction zone and concentric protection zone of a hydrothermal reactor without a protective liner, according to one embodiment of the present invention.

[0095] [Figure 13B] This is a cross-sectional top view of the reaction zone and concentric protection zone of a hydrothermal reactor equipped with a protective liner, according to one embodiment of the present invention.

[0096] [Figure 14A] This is a process flow diagram of a hydrothermal reactor according to one embodiment of the present invention.

[0097] [Figure 14B] This is a process flow diagram of a reactor according to one embodiment of the present invention.

[0098] [Figure 14C] This is a process flow diagram of a reactor according to one embodiment of the present invention.

[0099] [Figure 14D] This is a process flow diagram of a salinization module according to one embodiment of the present invention.

[0100] [Figure 15] A detailed process flow diagram of one embodiment of a hydrothermal reactor and method for SCWO applications.

[0101] [Figure 16] This is a diagram of multiple hydrothermal reactors arranged in a parallel configuration according to one embodiment of the present invention.

[0102] [Figure 17] This is a process flow diagram relating to one embodiment of the present invention.

[0103] [Figure 18] This is a process flow diagram relating to one embodiment of the present invention.

[0104] [Figure 19] This is a graph of the radial temperature profile as a function of reactor position in one embodiment of the present invention. [Modes for carrying out the invention]

[0105] Detailed description of the invention Specific embodiments of the present invention will be described in detail below. Examples of these embodiments are shown in the accompanying drawings. The present invention will be described with reference to these embodiments, but it should be understood that these embodiments are not intended to limit the present invention. On the contrary, the present invention is intended to encompass alternatives, modifications, and equivalents that fall within the spirit and scope of the present invention. The following disclosure provides specific details that will give a full understanding of the present invention. However, it will be apparent to those skilled in the art that the present invention can be carried out without these specific details.

[0106] Referring to the drawings, similar or corresponding parts in each figure are denoted by the same reference numerals. In particular, referring to the configurations and components shown in Figures 1 to 8B, it is understood that the present invention includes a modular regenerative hydrothermal reactor configured to carry out chemical reactions under harsh operating conditions for applications such as (but not limited to) the decomposition of recalcitrant pollutants in waste and / or wastewater. As shown in Figures 5, 6, and 7, the hydrothermal reactor of the present invention may be configured as multiple segments using the injection / bleeding devices shown in Figures 1 to 3E to carry out chemical reactions. Figures 9 to 16 show various modular regenerative hydrothermal reactors and methods for carrying out chemical reactions. Sections 1 and 2 below describe exemplary apparatuses and methods that utilize harsh operating conditions. Section 3 shows examples of exemplary embodiments of the reactors and methods of the present invention applied to SCWO, and Section 4 shows examples of exemplary embodiments of the reactors and methods of the present invention applied to subcritical reactions. Each embodiment will be described individually below, but features disclosed in any embodiment can be appropriately combined and applied to any other embodiment described herein. Section 1: Modular Regenerative Hydrothermal Reactor System

[0107] In some embodiments, the hydrothermal reactor 100 may include a tubular shell (e.g., a pressure vessel) 105 and an array of injection / bleeding devices 110 configured to enable controlled responses and / or transitions of chemical reactions in response to changes in reactor operating conditions resulting from radial injection of reactants, tangential injection of a fluid barrier, bleeding and regeneration, and an array of multiple devices operating in fluid communication.

[0108] Injection / bleeding device - fluid distribution and recovery

[0109] Embodiments of the present invention provide an injection / bleeding device configured to distribute / inject fluid into a section and to recover fluid from a preceding section. Several embodiments are shown in Figures 1, 2, 3 and 3A-3H. Figure 3A is a cross-sectional view showing one embodiment of the injection / bleeding device. In some embodiments, as shown in Figures 2, 3A, 3B, 3D, 3E, 3F and 3H, the injection / bleeding device 110 may include various fluid distribution channels and various liners corresponding thereto.

[0110] In some embodiments, the injection / bleeding device 110 may include various fluid distribution manifolds, namely: 1) a fluid distribution manifold that allows radial flow; 2) a fluid distribution manifold that allows tangential circumferential flow (e.g., flow along a tubular shell); and 3) a fluid distribution manifold for collecting tangential circumferential flow (e.g., flow flowing around a tubular shell). Multiple dimensions of the injection / bleeding body include outer diameter (OD), inner diameter (ID), and thickness, which are intended to be within the scope of the present invention in any embodiment.

[0111] In some embodiments, the injection / bleeding device 110 may inject reactants radially along the inner surface 110i through a plurality of primary outlets 112 arranged circumferentially on the inner surface 110i, as shown in Figures 1 and 4. The primary outlets 112 may be openings (e.g., nozzles) configured to inject each fluid radially toward the longitudinal axis 30 of the reactor (i.e., the central reaction zone 40). In such embodiments, a plurality of primary outlets 112 are provided and configured to supply a first fluid, a second fluid, or a combination thereof. In some embodiments, a plurality of outlets corresponding to a plurality of different additional fluids (e.g., may also be referred to as primary radial injectors) may be provided along the inner surface 110i. In such embodiments, the outlets for the first and second fluids are located on a common outlet plane for radial flow directed toward the central longitudinal axis 30, as shown in Figure 4.

[0112] In some embodiments, a plurality of first and / or second fluid outlets (i.e., any combination of primary radial injectors) may direct the fluid flow at multiple angles between each fluid outlet 112 and the longitudinal axis 30. In some embodiments, additional specific fluid outlets are arranged circumferentially around the inner surface 110i of the ring, as well as along the inner surface 110i at multiple longitudinal positions (i.e., above and / or below the first and / or second fluid outlets). These fluid outlets are intended to provide auxiliary control over the radial and longitudinal fluid profiles (e.g., to promote fluid flow and / or reaction, and / or to dilute / suppress it to act as a fluid damper) by injecting fluid radially at multiple angles between the fluid outlet and the longitudinal axis 30 (e.g., they may be referred to as auxiliary radial injectors). In some embodiments, the first and second fluids may be integrated into a plurality of single outlets common to both fluids (e.g., a coaxial injector). In some embodiments, the fluid outlets of the first, second (i.e., primary radial injector), and / or auxiliary fluid injector may be arranged in an alternating pattern. Multiple different dimensions of the diameters of the fluid outlets of the first, second (i.e., primary radial injector), and / or auxiliary fluid injector are within the scope of the invention. In some embodiments, the diameters of the fluid outlets of the first, second (i.e., primary radial injector), and / or auxiliary fluid injector may differ from each other.

[0113] As shown in Figures 3, 3A, and 3B, a plurality of first fluid outlets 112 are connected to a first fluid distribution manifold 210 that extends circumferentially around the ring structure and is connected to a first fluid inlet 201. In some embodiments, there may be multiple first fluid inlets 201. Similarly, for the second fluid, as shown in Figures 3C, 3D, and 3E, a plurality of second fluid outlets 112a are connected to a second fluid distribution manifold 211 that extends circumferentially around the ring structure and is connected to a second fluid inlet 202. In some embodiments, there may also be multiple second fluid inlets 202. In some embodiments, additional primary radial injectors and / or auxiliary radial injectors may be provided, and each specific fluid is similarly connected to its corresponding fluid distribution manifold and fluid inlet. In some embodiments, the fluid distribution manifolds are separated from each other by walls. In some embodiments, corresponding to each fluid, an outlet duct may be provided that connects the fluid outlet to the fluid distribution manifold. The outlet duct allows the fluid to flow from the distribution manifold to the outlet. In some embodiments, the first fluid distribution manifold 210 and the second fluid distribution manifold 211 may exist as a two-fluid distribution manifold.

[0114] A dual fuel manifold for a gas turbine engine (e.g., disclosed in U.S. Patent No. 7,654,088) can be applied to alternative embodiments for radially injecting reactants via a two-fluid manifold. In some embodiments, a spray-tip feed nozzle may be used with outlets 112, 112a to facilitate injection of reactants toward the longitudinal axis 30. Alternative embodiments may also include other injectors for radial injection of reactants. Examples, but not limited to, include coaxial injectors, post-expansion coaxial injectors, impact injectors, shear triple coaxial injectors, concentric tube injectors, and / or other injectors for atomizing / dispersing reactants toward the longitudinal axis 30.

[0115] Each fluid flow for radial injection is controlled independently. Factors influencing the fluid flow include injection pressure, the diameter of the fluid distribution manifold, the diameter of the fluid outlet, and other factors. In some embodiments, the fluid pressures in each fluid manifold may be different from each other, while in other embodiments they may be the same. In some embodiments, some or all of the fluid may be preheated before injection.

[0116] Injection of protective reactants / reagents in the circumferential direction

[0117] As shown in Figures 3A, 3D, 3F, and 3H, one or more injection rings concentric with the primary injector manifolds (210, 211) may be provided along the bottom surface of the injection / bleed ring device 110. These injection rings may include an outlet 113 for a third fluid and an outlet 114 for a fourth fluid. The flows of the third and fourth fluids may be injected from the first ring device Nx(110) and configured to flow along the longitudinal direction of the tubular shell to the second ring device Nx+1. In such embodiments, a plurality of outlets 113 and 114 may be arranged circumferentially around the bottom surface of the first ring device Nx. Corresponding outlets 205 and 206 may be arranged circumferentially around the top surface of the next ring device Nx+1. Outlets 113 and 114 are openings that penetrate the surface of the apparatus, allowing the respective fluids to flow coaxially with respect to the tubular shell until they reach outlets 205 and 206, thereby forming fluid film-forming zones or concentric protection zones as described elsewhere in this specification. In some embodiments, additional outlets corresponding to several different fluids may be provided in separate zones.

[0118] The third fluid outlet 113 and the fourth fluid outlet 114 are oriented along the longitudinal axis 30 and are positioned around a common outlet plane for coaxial flow adjacent to the tubular shell. The third fluid outlet 113 and the corresponding outlet 205 are positioned circumferentially adjacent to the tubular shell, and the third fluid flow forms a third fluid concentric protection zone. The fourth fluid outlet 114 and the corresponding outlet 206 are positioned circumferentially adjacent to the third fluid outlet 113, and the fourth fluid flow forms a fourth fluid concentric protection zone. The third and fourth fluids flow from ring device Nx to ring device Nx+1.

[0119] Multiple different dimensions of the diameters of the third fluid outlet 113 and the fourth fluid outlet 114, and the corresponding outlets 205 and 206, are included within the scope of the present invention. In some embodiments, the diameters of the third fluid outlet 113 and the fourth fluid outlet 114, and the corresponding outlets 205 and 206 are the same, and in other embodiments, they may be different. With respect to the arrangement of the multiple third fluid outlets 113 and the fourth fluid outlet 114, and the corresponding outlets 205 and 206, multiple different radial positions on the surface of the injection / bleed ring device 110 are also included within the scope of the present invention. In some embodiments, the third fluid outlet 113 and the fourth fluid outlet 114 located at the bottom of the outer circumference of the ring device 100 are channels as shown in Figure 2. In some embodiments, these channels may include milled channels, corrugated outer wall channels, Z-shaped channels, tubular cooling jacket channels, or other channels.

[0120] Referring to Figures 3A, 3D, 3F, and 3H, for the third fluid, a plurality of third fluid outlets 113 are connected to a third fluid distribution manifold 212 that extends circumferentially around the ring structure and is connected to a third fluid inlet 203. Similarly, for the fourth fluid, a plurality of fourth fluid outlets 114 are connected to a fourth fluid distribution manifold 213 that extends circumferentially around the ring structure and is connected to a fourth fluid inlet 204. Each fluid distribution manifold may be configured to distribute fluid to its corresponding fluid outlet. In some embodiments, additional specific fluids and their corresponding fluid outlets may be provided, each specific fluid outlet similarly connected to its corresponding fluid distribution manifold and fluid inlet. In some embodiments, corresponding to each fluid, an outlet duct may connect the fluid outlet to the fluid distribution manifold. The outlet duct allows the fluid to flow from the distribution manifold to the outlet. In some embodiments, the fluid distribution manifolds may be separated from each other by walls. Each fluid flow may be controlled independently. In some embodiments, the fluid pressures in each fluid manifold may differ from one another. In some embodiments, the reactants / reagents are preheated before injection.

[0121] Referring to Figures 2 and 13B, in some embodiments, a cylindrical liner 162 may be positioned between the third fluid outlet 113 and the fourth fluid outlet 114 (i.e., between the central reaction zone and the tubular shell). The liner 162 may be solid or porous. The liner may be fixed to the surface of the injection / bleeding device by being positioned in a groove 62g that allows for thermal expansion of the liner, as shown in Figure 2. In different embodiments, additional liners 162 may be provided between different concentric protection zones. The liner 162 may be fixed to the surface of the injection / bleeding device by being positioned in a groove 60g that allows for thermal expansion of the liner, as shown in Figure 2. The liner 162 may be positioned between and connected to a plurality of injection / bleeding devices 110. Positioning the liner 162 at any position along the longitudinal direction of the tubular shell is within the scope of the present invention.

[0122] In some embodiments, multiple cylindrical liners 162 may be arranged on the surface of the injection / bleeding device 110. Any radial position of the liner is within the scope of the invention. Each end of the liner fixed between the injection / bleeding devices 110 may be positioned at multiple radial positions on the surface of the device 110 so that the liner can be positioned at multiple angles. Any combination of porous and / or solid liners is within the scope of the invention. In some embodiments, any combination of liners may separate multiple concentric protection zones. For highly reactive chemical reactions, it is preferable to provide liners to isolate the central reaction zone from the tubular shell. In some embodiments, a pressure difference across the liner can drive a radially inward fluid flow through the porous liner from a third fluid concentric protection zone to a fourth fluid concentric protection zone. In some embodiments, this pressure difference may be used to provide auxiliary thermal / deposit / corrosion protection, facilitate the diffusion of reactants from the third fluid concentric protection zone to the fourth fluid concentric protection zone, provide purging to prevent backflow of reaction byproducts, and / or enable the reactor to transition to a layup state.

[0123] Circumferential bleeding of protective reactants / reagents

[0124] As shown in Figures 2, 3A, 3D, and 3H, in some embodiments, recovery inlets 205 and 206 for recovering the fifth and sixth fluids are included along the upper surface of the injection / bleed ring device 110. The flow of the fifth and sixth fluids is injected from the ring device 100Nx-1 (i.e., in the vertical configuration embodiment, the ring device Nx-1 is located above the ring device Nx) and flows to the ring device Nx along the axial length of the tubular shell for recovery. In such embodiments, a plurality of inlets 205 and 206 may be arranged circumferentially along the upper outer circumference of the device 110. The inlets 205 and 206 are openings that penetrate the surface of the device for the respective fluids to flow circumferentially along the tubular shell. In some embodiments, inlets corresponding to multiple different fluids may be provided. In some embodiments, the inlets located on the upper outer circumference of the device may include channels as shown in Figure 2. In some embodiments, these channels may include milled channels, corrugated outer wall channels, Z-shaped channels, tubular cooling jacket channels, or other channels.

[0125] The fifth fluid inlet 205 and the sixth fluid inlet 206 are oriented along the longitudinal axis 30 and are positioned around a common inlet plane for coaxial flow adjacent to the tubular shell. The fifth fluid inlet 205 is positioned circumferentially adjacent to the tubular shell, and the fifth fluid flow forms a fifth fluid concentric protection zone. The sixth fluid inlet 206 is positioned circumferentially adjacent to the fifth fluid inlet 205, and the sixth fluid flow forms a sixth fluid concentric protection zone. Multiple different diameters of the fifth fluid inlet 205 and the sixth fluid inlet 206 are within the scope of the present invention. In some embodiments, the diameters of the fifth fluid inlet 205 and the sixth fluid inlet 206 may be different from each other, and in other embodiments they may be the same. Multiple different radial positions of the fifth fluid inlet 205 and the sixth fluid inlet 206 on the surface of the injection / bleeding device 110 are also within the scope of the present invention. In some embodiments, the fifth fluid inlet 205 and the sixth fluid inlet 206 may be formed as channels arranged along the upper outer circumference of the device (see Figure 2).

[0126] As shown in the exemplary embodiments in Figures 3A, 3D, and 3H, for the fifth fluid, a plurality of fifth fluid inlets 205 are connected to a fifth fluid distribution manifold 214 that extends from and is connected to a fifth fluid outlet 115. Similarly, for the sixth fluid, a plurality of sixth fluid inlets 206 are connected to a sixth fluid distribution manifold 215 that extends from and is connected to a sixth fluid outlet 116. Each fluid distribution manifold distributes the fluid to its corresponding fluid outlet. In some embodiments, additional specific fluids and their corresponding fluid inlets may be provided, each specific fluid inlet similarly connected to its corresponding fluid distribution manifold and fluid outlet. In some embodiments, corresponding to each fluid, an outlet duct may connect the fluid outlet to the fluid distribution manifold. The outlet duct allows the fluid to flow from the distribution manifold to the fluid outlet. In some embodiments, the fluid distribution manifolds may be separated from each other by walls. Each fluid flow may be controlled independently. In some embodiments, the fluid pressures in each fluid manifold may differ from each other. The fluid from each fluid manifold is drawn in through the inlet, passes through the distribution manifold, and is discharged from the injection / bleeding device for regeneration. In some embodiments, the fluid is regenerated by treatments that may include chemical, thermal, and / or physical means known to those skilled in the art to restore it to its state before injection into the reactor.

[0127] Referring to Figures 2 and 13B, in some embodiments, a cylindrical liner 162 may be positioned between the fifth fluid inlet 205 and the sixth fluid inlet 206. The liner may be solid or porous. The liner may be fixed to the surface of the injection / bleeding device by being positioned in a groove 62g that allows for thermal expansion of the liner. In some embodiments, multiple liners may be positioned on the surface of the injection / bleeding device 110 to separate different fluid inlets. Any radial position of the liner is within the scope of the invention. Any combination of porous and / or solid liners is within the scope of the invention. In some embodiments, any combination of liners may separate multiple concentric protective zones. The liners are positioned between multiple injection / bleeding devices 110 and connected to them. Each end of the liner fixed between the injection / bleeding devices 110 may be positioned at multiple radial positions on the surface of the device 110 so that the liner can be positioned at multiple angles. Positioning the liner at any position along the longitudinal direction of the tubular shell is within the scope of the invention. For highly reactive chemical reactions, it is preferable to provide a liner to isolate the central reaction zone from the tubular shell.

[0128] In some embodiments, as shown in Figures 2, 3A, 3D, 3H, 4, and / or 5, a single fluid that is uniform along the entire length of the longitudinal axis 30 of the tubular shell (i.e., forming a uniform concentric protection zone along the length of the longitudinal axis) may reside in the isolated annular chamber 280. This fluid is isolated from exposure to other different fluids by a solid liner supported on the outer surface of 110. As shown in Figures 4 and 5, the isolated annular chamber 280 may be located between the tubular shell 105 and the third fluid concentric protection zone / fifth fluid concentric protection zone 138. The inlet 134 and outlet 135 for the isolated annular chamber 280 may be perforated and may be formed through the injection ring device (Nx) 110, as shown in Figure 7. This eliminates the need for a circumferential fluid distribution manifold. The inlet 134 may be connected to a duct connected to the outlet, which extends parallel to the longitudinal axis 30 and is isolated from any fluid distribution manifold present within the apparatus 110. The separation annular chamber 280 is configured so that the fluid flows continuously along the length of the longitudinal axis (e.g., from Nx-1 through Nx to Nx+1). The fluid for this separation annular chamber may be injected and discharged at any position along the axial length of the shell via perforated injection / discharge ports.

[0129] The material of the injection / bleeding apparatus can be any suitable material that is suitable for the chemical reaction and / or operating conditions. In some embodiments, the outer surface of 110 may be provided with a protective coating for heat and / or corrosion resistance. In some embodiments, the heat and / or corrosion resistance coating includes a ceramic layer. In some embodiments, the ceramic layer includes zirconia such as yttria-stabilized zirconia (YSZ) and / or metal oxide species. In some embodiments, any portion of the outer surface of 110 may include a film cooling layer. In some embodiments, the film cooling layer includes a porous or non-porous liner covering any portion of the inner surface of 110, the liner containing a continuous fluid flow to remove heat from any portion of the surface, and also providing means to isolate the surface of 110 from the longitudinal axis 30 and further isolate all outlets 112, 112a, 113, 114 and / or inlets 205, 206 from the cooling layer. In some embodiments, a heat shield may be present on any portion of the inner surface of 110.

[0130] In some embodiments, the injection / bleeding device 110 is assembled / constructed from a plurality of individual injection and / or bleeding segments, each segment comprising at least one fluid distribution manifold and / or a two-fluid distribution manifold. All injection ring device segments are connected to one another by means that make the individual injection and / or bleeding rings of the device 110 separable in order to facilitate assembly and disassembly. In this embodiment, in addition to the entire reactor being modular, the injection / bleeding device 110 itself also constitutes a modular structure. If a portion of the fluid distribution manifold becomes unusable, instead of replacing the entire injection / bleeding device 110, only the injection or bleeding segment containing the corresponding fluid distribution manifold can be removed and replaced, thereby greatly simplifying reactor maintenance. Alternatively, the injection / bleeding device 110 may be configured as a single unit including each fluid distribution manifold and / or a two-fluid distribution manifold joined to one another by any means known to those skilled in the art.

[0131] Tubular shell assembly

[0132] Figures 4, 5, 6, 7, and 8A / 8B show different diagrams of one embodiment of the tubular shell supporting multiple injection / bleeding devices 110 of the present invention. The present invention is not limited to any particular embodiment (or particular operating conditions and / or chemical reaction), but for convenience, the illustrated embodiment will be described.

[0133] In the embodiments shown in Figures 4 to 7, the elements constituting the tubular shell assembly include an injection / bleeding device, an inlet, and an outlet. The constituent material of the tubular shell can be any suitable material that is suitable for the chemical reaction and operating conditions. In some embodiments, the tubular shell includes a tubular pressure vessel. In some embodiments, the inner surface of the tubular shell may be smooth. In some embodiments, the inner surface of the tubular shell may have a ribbed surface. The dimensions and thickness of the tubular shell must be suitable for the operating conditions and must comply with all relevant standards (e.g., ASME Pressure Vessel Standards, ASME Section VIII, Div 1 and / or ASME Power Piping Code B31.1, etc.).

[0134] The injection / bleeding device may be supported within a tubular shell using various fastening and connecting means as shown in Figure 3G. In some embodiments, the outer surface of the injection / bleeding device 110 may be modified in various ways to support the placement of the ring within the tubular shell in any embodiment. For example, as shown in Figures 3G and 4, the injection / bleeding device 110 may have flange and / or clamp connections 125 (e.g., Grayloc in the improved example shown in Figure 3G). TM It is supported within the tubular shell 105 between clamp connections such as the above.

[0135] In embodiments of the present invention, the chemical injector / ejector apparatus and tap 126 may be drilled into the hub 127 for each specific fluid inlet and outlet (e.g., 201, 202, 203, 204, 115, 116) and directly connected to the injection / bleeding apparatus 110, as shown in Figure 4. Multiple circumferential and / or axial placement positions of the injector / ejector apparatus are within the scope of the present invention. In some embodiments, the injection / bleeding apparatus may be supported between flange and / or clamp connections that divide the tubular shell into modular sections (Nx). The use of flange and / or clamp connections supporting the injection / bleeding apparatus may be advantageous in that it enables modularization of the reactor and improves flexibility, expandability, and / or other factors. In some embodiments, the injection / bleeding apparatus may be directly supported within the tubular shell (i.e., the taps for the injectors / ejectors are directly connected to the apparatus without the use of clamp and / or flange connections). In some embodiments, the injection / bleeding device may be supported directly within the tubular shell (i.e., with the injector / ejector taps directly connected to the ring device), or it may be supported between flanges and / or clamp connections, as shown in Figures 3G and 4. The tubular shell, injection / bleeding device, liner, and / or all associated connections are designed by any means (e.g., expansion joints) to absorb longitudinal and / or radial expansion due to temperature and / or other fluctuations. In some embodiments, a concentric protection zone is demarcated by spacers that support the fluid flow within the zone.

[0136] In embodiments of the present invention, each injection / bleeding device (Nx) arranged along the axial length of the tubular shell constitutes a stage of the reactor. In some embodiments, there may be multiple stages in the reactor. Figures 5 to 7 show a reactor assembly having a tubular shell 105 (i.e., segments 105a to 105d) supporting five injection / bleeding devices 110 connected along its longitudinal direction to a porous liner and / or solid liner 162 by clamp and / or flange connections 125 (representing five modular divisions and five stages). The number of injection / bleeding devices and the spacing between each ring device along the axial length of the reactor are determined based on the operating conditions of the reactor, chemical reactions, materials, temperature / concentration gradient profile, and other relevant parameters, and multiple distances between ring devices are within the scope of the present invention. In some embodiments, each injection / bleeding device along the axial length of the reactor may be operated under different operating conditions.

[0137] In some embodiments, the reactor's tubular shell has open inlet and outlet ends, constituting a flow-through reactor. As shown in Figure 5, the illustrated tubular shell 105 (i.e., segments 105a to 105d) has open inlet 130 and outlet 131, and represents a simple improvement over a conventional PFR with an injection / bleeding device 110 incorporated along its axial length. For example, even in an existing flow-through PFR reactor, the advantages of the present invention can be obtained by installing an injection / bleeding device at any position along the axial length of the reactor. In some embodiments, inlet ports, outlet ports, and / or (clamp and / or flange) connections may be provided along the axial length of the tubular shell.

[0138] In some embodiments, the tubular shell may be oriented horizontally or vertically. Referring to the exemplary embodiments shown in Figures 4–7, the tubular shell 105 is positioned vertically, and its upper end 100t and lower end 100b are closed by blind flanges and / or clamp connections. The tubular shell is fluid-tight and may be closed by any means known to those skilled in the art. In some embodiments shown in Figures 4–7, the reactor is described as operating as a downflow reactor, where all incoming fluid flows downward. In alternative embodiments, the reactor may operate as an upflow reactor, where all incoming fluid flows upward. In yet another alternative embodiment, the reactor may operate in a configuration including a combination of upward and / or downward flow, and / or zones with counterflow. Note that different orientations may result in different locations of the injection / discharge points along the longitudinal direction of the reactor, tubular shell, and / or injection / bleeding apparatus (i.e., including the arrangement of inlets and outlets on the injection / bleeding apparatus). As shown in Figure 6, a schematic diagram is provided which includes an inlet port 134, a discharge port 135, and clamp and / or flange connections 125 capable of supporting multiple injection / bleeding devices 110.

[0139] Referring to the embodiments shown in Figures 4 and 6, a plurality of inlet ports 134 may be connected to the hub 127 of the tubular shell 105. These inlet ports are provided with chemical injectors such as injection quills 126 or other means known to those skilled in the art, and are connected to an injection / bleeding device 110. This enables radial injection of reactants / reagents through a first fluid inlet 201, a second fluid inlet 202, and / or a plurality of other fluid inlets, as well as tangential injection through a third fluid inlet 203, a fourth fluid inlet 204, and / or a plurality of other fluid inlets. A plurality of other fluids may be injected through the inlet injection ports 134 at a plurality of locations along the tubular shell 105. A plurality of discharge ports 135 may be connected to the hub 127 of the tubular shell 105. These discharge ports are provided with chemical ejectors 126 and are connected to the injection / bleeding device 110, which may enable bleeding of reactants / reagents through a fifth fluid outlet 115, a sixth fluid outlet 116, and / or a plurality of other fluid outlets. Multiple other fluids can be discharged through the 135 at multiple locations along the tubular shell 105. Referring to Figures 6 and 7, in some embodiments, one or more longitudinal ports 136 may be located at both ends of the tubular shell 105 and used for injecting or discharging fluids. In some embodiments, the longitudinal ports 136 may be located at one end of the tubular shell 105. In some embodiments, the longitudinal ports 136 may include an injection port 134. In some embodiments, the longitudinal ports 136 may include a discharge port 135.

[0140] Referring to Figure 7, in some embodiments, the tubular shell assembly may further comprise an injection / bleeding device 110 positioned on top of the tubular shell, fixed between the blind flange and / or clamp connection 100t and the tubular shell 105. This embodiment of the injection / bleeding device fixed to 100t may not have circumferential bleeding (as described with respect to Figure 7) but may be configured to have circumferential injection, and may also be configured to have a liner as described anywhere in this specification. In addition, 110 fixed to 100t may be configured for radial injection into a longitudinal port 136 which functions as an injection port 134 or an discharge port 135. In an alternative embodiment, for 110 fixed to 100t, instead of radial injection, a series of primary longitudinal injectors may be positioned on the centerline of the longitudinal axis 30, as shown in 136, and reactants may be injected into 134 to form a central reaction zone along the centerline of the longitudinal axis (i.e., guided toward the bottom).

[0141] Similarly, referring to Figures 6 and 7, in some embodiments the tubular shell assembly may further comprise an injection / bleeding device 110 located at the bottom of the tubular shell, fixed between the blind flange and / or clamp connection 100b and the tubular shell 105. This embodiment of the injection / bleeding device fixed to 100b may not have circumferential injection (as described with respect to Figures 6 and 7) but may be configured to have circumferential bleeding, and may also be configured to have a liner as described anywhere in this specification. In addition, 110 fixed to 100b may be configured for radial injection into a longitudinal port 136 which functions as an injection port 134 or an discharge port 135. In an alternative embodiment, for 110 fixed to 100b, instead of radial injection, a series of primary longitudinal injectors can be positioned along the centerline of the longitudinal axis, as shown in 136, to inject the reactants into 134 from the bottom of the tubular shell along the centerline of the longitudinal axis to form a central reaction zone (i.e., guiding the reactants upwards).

[0142] In some embodiments, a reactor comprising a tubular shell and / or one or more injection / bleeding devices can operate under multiple operating conditions and respond to changes in the system. For example, at multiple locations along the length of the tubular shell, the injection / bleeding devices may be configured to act as neutralization zones, thereby neutralizing and / or transitioning the chemical reaction and the corresponding reactor operating conditions.

[0143] In some embodiments, the injection / bleeding apparatus operates in fluid communication, and each apparatus responds to potential changes in reaction conditions. In some embodiments, measuring devices for monitoring relevant chemical reaction parameters are located internally and / or externally along the axial length of the tubular shell. These parameters include pressure, temperature, pH, conductivity, cation conductivity, oxidation-reduction potential (ORP), chemical oxygen demand (COD), total organic carbon (TOC), flow rate, water level / fluid level, dissolved oxygen (DO), iron (Fe), sodium (Na) + The system may include measuring instruments / devices for monitoring parameters such as, but not limited to, Ca, Mg, chloride, sulfate, alkalinity, silica, phosphate, ammonia, H2S, CO, NOx, SOx, concentrations of various components, or other sensors. In some embodiments, the fluid is sampled (i.e., collected) at multiple locations and analyzed for multiple parameters.

[0144] In such embodiments, the reactor operation and control scheme is automated. Data may be acquired and stored from a monitoring device, and feedback acquired from the monitoring device is transmitted to a control scheme / configuration for the reactor and injection / bleeding equipment, and the operation of the reactor and / or injection / bleeding equipment is modified as a result of the feedback response from the control scheme / configuration. An example of such a scenario is that the reaction temperature in the central reaction zone is monitored by a thermocouple device, the thermocouple detects an increase in the reaction zone temperature, and the injection / bleeding equipment responds to this temperature gradient by reducing the flow rate of reactants upstream, downstream, and / or in the injection / bleeding equipment located near the thermocouple (e.g., by valve operation). The operation and control of the reactor depend on the chemical reaction and operating conditions and are known to those skilled in the art.

[0145] In some embodiments, the reactor 100 may be remotely operated, in which case the reactor is physically located within an enclosure, and control of the reactor is performed from a location outside the reactor enclosure (i.e., except for any monitoring devices). During normal operation, the gas produced by the reaction is scrubbed (i.e., treated) as needed and discharged into the atmosphere. In the event of leakage and / or other events, the fluid is contained within the enclosure to ensure the safety of the personnel. Means for controlling the reactor may include a programmable logic controller (PLC), a supervisory control and data acquisition (SCADA) system, a distributed control system (DCS), and / or other methods. Furthermore, means for controlling the automated operation of the reactor may include a control scheme based on machine learning and / or artificial intelligence.

[0146] In some embodiments, reactor 100 may be operated continuously or as a batch process. In some embodiments, multiple reactors may be operated in parallel as shown in Figure 16 to ensure a certain range of turndown capability and redundancy. In some embodiments, multiple reactors may be operated in series. In some embodiments, when multiple reactors are operated in series, each reactor may be operated under different operating conditions. In some embodiments, multiple reactors may be operated in parallel as shown in Figure 16 and configured to send the effluent to a common processing module (e.g., for solids processing).

[0147] According to one aspect of the present invention as described herein, the reactor can be operated under multiple conditions, including low pressure / low temperature (<100°C, <1 MPa), low pressure / high temperature (>100°C, <1 MPa), high-pressure pressurized water (>20°C, >1 MPa), steam (>100°C, >0.1 MPa), wet air oxidation (WAO) conditions (120-350°C, 0.1-20 MPa), hydrothermal oxidation (HTO) conditions (>100°C, >0.1 MPa), SCWO (>374°C, >22.1 MPa), SCWG (>374°C, 22.1 MPa), hydrothermal liquefaction (250-350°C, 4-20 MPa), or other conditions known to those skilled in the art. In some embodiments, the reactor can be operated under multiple operating conditions at multiple locations within the reactor or in other parts of the reactor system.

[0148] Section 2: Operating Methods / Protection Methods

[0149] A reactor operation method for protecting the reactor from severe chemical reactions may include isolating the chemical reaction from the reactor using radial and / or axial flow of a fluid barrier scheme that may include initiators, inhibitors, and / or insulating chemical species, and bleeding and regenerating the fluid barrier via an array of fluid-connected devices to respond quickly to changes in reactor operating conditions. This is a general method considering various severe chemical reactions that may have properties including high temperature and / or high pressure operating conditions, scaling and / or the presence of corrosive components, high or low pH conditions, thermal runaway and / or autocatalytic reactions, oxidative conditions that generate large amounts of heat, and / or harmful reactants and / or reaction by-products, and is not intended to limit the embodiments of the present invention. More detailed exemplary applications of methods for protecting SCWO are described in Section 3.

[0150] Figure 9 is a schematic diagram of an embodiment having multiple fluid layers (i.e., concentric protection zones) (ix) consisting of i1 (137), i2 (138), and i3 (139) surrounding the central reaction zone (R, 40) and the corresponding inward radial flow. Although three concentric protection zones are shown in Figure 9, it should be understood that in other embodiments, more or fewer concentric protection zones may be provided. As shown in Figure 9, the first concentric protection zone i1 (137) is adjacent to the central reaction zone 40, the next concentric protection zone i2 (138) is adjacent to the first concentric protection zone i1 (137), and the third concentric protection zone i3 (139) is adjacent to the second concentric protection zone i2 (138). The inward radial flow in 137, 138, and / or 139 is indicated by solid or dashed arrows pointing toward the central reaction zone (R) 40. Solid arrows indicate the presence of inward radial flow, while dashed arrows indicate optional inward radial flow. Optional inward radial flow indicates the presence of a solid liner, or simply the absence of a fluid layer in a given zone (ix).

[0151] In some embodiments, as shown in Figure 13A, only one liquid film-forming zone 137 exists, and no liner is provided to separate this liquid film-forming zone 137 from the central reaction zone 40. In other embodiments, for a given chemical reaction, at least two fluid layers (e.g., concentric protective zones consisting of i1(137) and i2(138)) may be provided between the central reaction zone 40 and the reactor wall 105, as shown in Figure 13B. In some embodiments, a porous liner 162 may separate i1(137) and i2(138). In other embodiments, a solid liner 162a may separate i1(137) and i2(138). In other embodiments, no liner may be provided between i1(137) and i2(138). In some embodiments, spontaneous mixing of fluids may occur between i1(137) and i2(138). In some embodiments, a porous liner 160 may separate i2(138) and i3(139). In some embodiments, the solid liner 160 may separate i2(138) and i3(139). In some embodiments, no liner may be provided between i2(138) and i3(139). In some embodiments, spontaneous mixing of the fluid may occur between i2(138) and i3(139).

[0152] Figure 10 shows an exemplary embodiment of multiple fluid layers (i.e., concentric protective zones) (ix), namely i1 (137), i2 (138), and i3 (139), surrounding the central reaction zone (R) 40, and the corresponding radial and axial flows in a given reactor section (Nx) 141. Figure 10 shows an exemplary embodiment of a reactor in which both ix and R are operated as downflows, in which case the axial flow of ix includes a downflow from Nx-1 (142) to Nx (141), and the fluid is bled for regeneration (Gx) 143. Furthermore, in Figure 10, the axial flow of ix includes a downflow from Nx (141) to Nx+1 (144), and the fluid is bled at Nx+1 (144) for regeneration (Gx+1) (145). Similarly, in Figure 10, Nx-1 receives the fluid flow at ix from Nx-2 (not shown) and is then bled for regeneration (Gx-1)(146). In some embodiments, R and ix may be upward flows. In some embodiments, R may be either an upward or downward flow, and ix may be an upward and / or downward flow in any combination. In some embodiments, any existing ix may be an upward and / or downward flow in any combination. Inward radial flow is indicated by solid or dashed arrows pointing towards the central reaction zone. Solid arrows indicate the presence of inward radial flow, and dashed arrows indicate optional inward radial flow. Optional inward radial flow indicates the presence of a solid liner, or simply the absence of a fluid layer at ix. Axial flow is indicated by solid or dashed arrows shown between Nx-1, Nx, and Nx+1. Solid arrows indicate the presence of axial flow at a given ix, and dashed arrows indicate optional axial flow at ix. The optional axial flow indicates that there may be no fluid layer corresponding to ix. In Figure 10, the solid and dashed arrows pointing to 137, 138, 139, and 40 illustrate a particular embodiment, and it should be understood that in other embodiments, different combinations of solid or dashed arrows (indicating different flows) may be provided.

[0153] Figure 11 shows one embodiment of a flow-through reactor. In some embodiments, as shown in Figure 11, the reactant feed stream 147 is injected radially into the reactor and flows radially and axially through the central reaction zone 40 of the reactor. Meanwhile, ix (i.e., i1(137), i2(138), and / or i3(139)) is injected circumferentially along the reactor wall from Nx(141), and then ix (i.e., i1(137), i2(138), and / or i3(139)) is bled 145 from Nx+1(144). Similarly, ix injected from Nx-1(142) is bled from Nx(141)(143). The bleed stream of ix recovered from each Nx is processed and then recycled back to Nx. In some embodiments, each Nx reactant feed stream and / or ix feed stream may be operated under multiple operating conditions.

[0154] In embodiments of the present invention, each ix present corresponds to at least one of the following zone classifications: initiator (i), inhibitor (i), and / or insulator (i). For example, the presence of initiator ix may mean a fluid that maintains the reaction in R at a more controlled and / or reduced rate. For example, the presence of inhibitor ix may mean a fluid that prevents the reaction from proceeding in R by trapping the reactants. For example, the presence of insulator ix may mean a fluid that insulates the reactor.

[0155] All combinations of zones present in the reactor constitute scheme iii. In some embodiments, a combination of two zones present in the reactor constitutes scheme ii. However, due to the thermal, chemical, and / or physical properties of the fluid, the properties of ii may extend to additional i categories even if no additional fluid layers are present. For example, even if only two different fluid layers exist whose primary properties correspond to ii, these fluid properties may include additional properties corresponding to iii. For example, a fluid may have catalytic properties that initiate the reaction (initiator category) while also having properties that reduce heat flow from R (insulator category). Another example is a fluid that inhibits the reaction (inhibitor category) while also reducing heat flow from R (insulator category). In different embodiments, different combinations of initiators and / or inhibitors and / or insulators may be used to achieve different results. To achieve the objectives of different methods, it is beneficial to improve the effectiveness and safety of the reaction and reduce cost / complexity by incorporating a combination of multiple categories (e.g., initiators, inhibitors and / or insulators) into a given concentric protection zone.

[0156] Section 3 Hydrothermal reactors and protection methods for SCWO

[0157] The present invention is not intended to be limited to specific operating conditions and / or chemical reactions. For illustrative purposes and for convenience of explanation only, and not intended to be limiting, one embodiment of the apparatus (which may include any disclosures described in Section 1) and protection method (which may include any disclosures described in Section 2) of the present invention is described in this Section 3 based on a central reaction zone 40 under SCWO conditions (i.e., >374°C, >22.1 MPa) for mineralizing an organic compound in the presence of an inorganic compound.

[0158] In this exemplary embodiment, Figures 12A and 12C show a general process flow diagram for the mineralization of organic compounds in waste (e.g., wastewater for convenience of explanation) in the presence of inorganic compounds, with the reaction carried out under SCWO conditions (i.e., >374°C, >22.1 MPa). The general process flow of the reactor apparatus and method may be configured such that wastewater 348, reactants (e.g., oxidizing agent) 349, and protective fluid reagent 350 are supplied to the reactor 100 under pressurization. The wastewater and oxidizing agent are maintained for an appropriate residence time under operating conditions for the reaction, and the treated distillates 352 and brine 353 are quenched, further treated, and depressurized (i.e., gas-liquid separation) before further treatment and / or discharge. The protective fluid reagent 350 is pressurized and injected into the reactor 100 to form a concentric protective zone and maintain an appropriate residence time to provide a protective fluid barrier, after which it may be bled out of the protective zone and processed (354) (i.e., regenerated) and further recirculated (355) to the reactor 100.

[0159] Figure 15 shows a more detailed process flow diagram of Figure 12A for the mineralization of organic compounds in waste (e.g., wastewater) in the presence of inorganic compounds, carried out under SCWO conditions (i.e., >374°C, >22.1 MPa). In some embodiments, inorganic compounds may not be present in the waste in the SCWO application. Figure 18 also shows an alternative embodiment of the detailed process flow diagram.

[0160] Organic / inorganic compound reactor supply source (348)

[0161] Waste / wastewater 348 can be any source containing organic and / or inorganic compounds. Any organic compound can be oxidized under (usually excessive) stoichiometric conditions at appropriate temperatures and residence times. Hundreds of thousands of organic compounds exist, and this disclosure is not limited to any particular compound. In some embodiments, the organic compound in question may be hazardous, toxic, and / or carcinogenic. Examples of organic compounds include organohalogens, polychlorinated biphenyls, pesticides, solvents, disinfection by-products, pharmaceutical compounds, sewage sludge, chemical weapons agents, ethylbenzene, toluene, xylene, carbon tetrachloride, phenols, 1,4-dioxane, diethyl ether, furans, dioxins, acrylonitrile, alkylphenol ethoxylates, acrolein, 2,4-dinitrophenol, 2-methyl-4,6-dinitrophenol, dichlorobenzenes, ethylene dichloride, vinylidene chloride, 1,2-dichloroethylene, methylene chloride, perchloroethylene, methylchloroform, trichloro Examples include roethene, monochloroethene, methyl tert-butyl ether, gasoline oxygenated compounds, lindane, chlordan, DDT, triazines, acetanilides, chlordan, dierdrin, aldicarb, endocrine disruptors, chemicals derived from personal care products, microplastics, acrylamide, epichlorohydrin, VOCs, surfactants, formaldehyde, trichloroacetic acid, phthalates, anilines, polycyclic aromatic hydrocarbons, trihalomethanes, bromodichloromethane, dibromochloromethane, haloacetic acids, dichloroacetic acid, nitrosamines, and / or other compounds known to those skilled in the art. In some embodiments, a hydrothermal reactor carries out a chemical reaction that defluorinates (i.e., cleaves at least one carbon-fluorine bond) and / or mineralizes (i.e., the compound contains at least one carbon-fluorine bond) the PFAS. PFAS compounds may include the following list: PFOA, PFOS, PFNA, PFHxS, PFBS, HFPO-DA, TFA, TFMS, 2233-TFPA, PFBA, PFPeA, PFHxA, PFHpA, PFDA, PFUnA, PFDoA, PFTrDA, PFTeDA, NMeFOSE, PFPeS, PFHpS,PFNS, PFDS, PFDoS, 4:2FTS, 6:2FTS, 7:3FTCA, 8:2FTS, PFOSA, NMeFOSA, NEtFOSA, NMeFOSAA, NEtFOSAA, NEtFOSE, ADONA, PFMPA, PFMBA, NFDHA, 9CI-PF3ONS, 11CI-PF3OUdS, PFEESA, 3:3 FTCA, 5:3FTCA, 7:3FTCA, 13C4-PFBA, 13C5-PFPeA, 13C5-PFHxA, 13C4-PFHpA, 13C8-PFOA, 13 C9-PFNA, 13C6-PFDA, 13C7-PFUnA, 13C2-PFDoA, 13C2-PFTeDA, 13CC3-PFBS, 1303-PFHxS, 13 C8-PFOS, D3-NMeFOSAA, PFO2HxA, PFO3OA, PFO4DA, PFO5DA, PEPA, PFECA_B, PFECA_G, D5-NE tFOSAA, 13C2-4:2FTS, 13C2-6:2FTS, 13C2-8:2FTS, 13C3-HFPO-DA, D7-NMeFOSE, D9-NEtFOS E. Acid, PFECA B, R-EVE, PFPrA, FHSAA, 6:2FTA, (2,2,3,3,5,5,6,6-Octafluoro-4-[1,2,2-Trifluoro-2-(2,2,2-Trifluoroethoxy)ethyl]morpholine, TBBP, TBMOPP, 2-FPDA, N-TamP-FhxSA, 3,5-Bis(heptafluoropropyl)-1H-1,2,4-Triazole, C10H3F18NO2, C13H3F 18N3O4, C15H2F13N2O2S, C7H3F12NO2, MeFBSEA, PFO5DA, NVHOS, PES, PFDoA, PFHpA, PFTeA, PFTriA, PFUnA, PFPe S, 10:2FTS, NEtFOSAA, NEtPFOSA, NEtPFOSAE, NMeFOSAA, NMePFOSA, NMePFOSA, NMePFOSAE, PFDOS, PFOSA, PFODA,or combinations thereof. As is known to those skilled in the art, thousands of PFAS compounds exist, and this list is not limited to compounds including organic compound feedstocks. In some embodiments, the total concentration of PFAS in the waste feedstream (e.g., according to EPA Method 1633) includes >1,000 ppm, <1,000 ppm, <100 ppm, <50 ppm, <10 ppm, <1 ppm, <100 ppb, <10 ppb, <1 ppb, <700 ppt, <500 ppt, <250 ppt, or <100 ppt). In some embodiments, the organic source to be treated is selected from the following list: industrial wastewater, leachate, landfill leachate, aqueous film-forming foam fire extinguishing agent (AFFF), municipal sewage, primary treated water, secondary treated water, tertiary treated water, foam separation residue, brine, resin regeneration by-product stream or brine, activated carbon regeneration by-product stream, novel adsorbent regeneration by-product stream, groundwater, drinking water, drinking water residue, rainwater, semiconductor wastewater, chemical manufacturing wastewater (primary and secondary manufacturing), metal finishing and plating wastewater, textile wastewater, paper product wastewater, petroleum industry wastewater, steel industry wastewater, aluminum industry wastewater, food and beverage wastewater, washing water, biosolids, membrane concentrates, thermal desorption condensates, scrubber wastewater, stack discharge wastewater, soil washing water, aqueous solid slurry (activated carbon, ion exchange resin, soil, chemical reaction precipitates, etc.), or combinations thereof. Any of these sources may contain, in any form and combination, multiple non-toxic substances such as sulfates, bicarbonates / carbonates, chlorides, silica, magnesium, calcium, iron, mercury, cadmium, zinc, aluminum, copper, cobalt, sodium, arsenic, barium, borates, bromides, fluorides, lead, lithium, manganese, nitrates, nitrites, phosphates, selenium, potassium, strontium, suspended solids, hydrogen sulfide, and / or ammonia.

[0162] Referring to Figure 15, in some embodiments, the wastewater 348 is optionally pretreated 356 before being introduced into the hydrothermal reactor 100 for chemical reaction. In some embodiments, the wastewater to be subjected to the chemical reaction is optionally supplied to the hydrothermal reactor without pretreatment. Whether or not pretreatment is required depends on the properties of the wastewater, as is known to those skilled in the art. Various pretreatment options include, but are not limited to, flocculation, flocculation, filtration, adsorption (e.g., activated carbon, ion exchange, etc.), membrane separation (e.g., reverse osmosis, nanofiltration, ultrafiltration, electrodeionization, etc.), degassing, chemical precipitation, disinfection, aeration, pH adjustment (i.e., raising or lowering), temperature adjustment (i.e., heating or cooling), foam separation, clarification, dilution, gravity sedimentation (or static sedimentation), centrifugal sedimentation, dissolved air flotation, concentration, wet scrubbing, mechanical dehydration, absorption processes, electrochemical processes, liquid-liquid extraction processes, solid-liquid extraction processes, chemical catalyst regeneration, crystallization, magnetic field treatment, chemical oxidation, chemical reduction, oxidizing agent / oxygen removal, natural treatment systems, UV treatment, distillation, stripping, humidity / gas drying control, moisture removal, activated alumina treatment, metal recovery, or any combination thereof.

[0163] Referring to Figure 15, in some embodiments, the wastewater 348 is optionally preheated 357 before being introduced into the reactor 100. The means selected for preheating depends on the available heat source. In some embodiments, the wastewater feedstream is not preheated. In some embodiments, the wastewater feedstream is preheated by heat recovery from the reactor effluent 358. In some embodiments, the feedstream is preheated via a heat exchanger that recovers heat from the reactor effluent (i.e., a combination of 357 and 358). In a different embodiment, the feedstream is preheated via a heat exchanger that recovers heat from the reactor effluent (i.e., a combination of 357 and 358), and the wastewater feedstream 348 contains very high concentrations of organic compounds and very low concentrations of inorganic components. In yet another embodiment, the feedstream is preheated via a heat exchanger that recovers heat from the reactor effluent (i.e., a combination of 357 and 358), and the wastewater feedstream 348 contains very high concentrations of organic compounds and no inorganic components.

[0164] In some embodiments, the inflow may be preheated by the use of an electric surface heater or other means during reactor startup and / or shutdown. In some embodiments, an auxiliary organic fuel (co-fuel) 359 may be used to increase the calorific value of the wastewater 348 and / or during reactor startup. In some embodiments, the co-fuel may be used during reactor startup and not required after reaching a predetermined temperature. In some embodiments, the co-fuel may include alcohols such as ethanol, methanol, or IPA, diesel, methane, gasoline, kerosene, biogas, or other fuels. In some embodiments, the mixing ratio of the co-fuel 359 and wastewater may be adjusted using an operating valve. In some embodiments, the wastewater and co-fuel may be injected into the reactor separately at multiple locations. Referring to Figures 15, 6, and 4, the wastewater supply stream 348 is connected to pressurized supply lines 360, 361, 362, and 363, and further connected (i.e., via 126) to the inlet injection port 134 of the tubular shell 105 of reactor 100, which is connected to the radial injection inlet 201 of the injection / bleed ring 110.

[0165] Oxidizing agent source (349)

[0166] In embodiments of the present invention, the oxidizing agent feed stream may include compressed air, oxygen, hydrogen peroxide, ozone, permanganate, persulfate, or other oxidizing agents. In some embodiments, the oxidizing agent may be mixed with deionized water. In some embodiments, the oxidizing agent is preheated before injection into the reactor (364). In some embodiments, the oxidizing agent is preheated via a heat exchanger that recovers heat from the reactor effluent (i.e., a combination of 358 and 364). In some embodiments, the oxidizing agent is preheated to >100°C, >200°C, >300°C, >350°C, >370°C, or >390°C. In some embodiments, the oxidizing agent is generated electrochemically in situ. In some embodiments, a high concentration of the oxidizing agent is maintained within the reaction zone. In some embodiments, the oxidizing agent concentration is <1 wt%, >1 wt%, >5 wt%, >10 wt%, >15 wt%, >20 wt%, >25 wt%, >30 wt%, >35 wt%, >140 wt%, >50 wt%, >60 wt%, or >70 wt%. In some embodiments, a high oxidizing agent concentration is maintained within the reaction zone, but at some locations within the reaction zone, it falls below the COD requirements and / or stoichiometric requirements necessary for the oxidation of the organic compound. Referring to Figures 15, 6 and 4, the oxidizing agent supply stream 349 is connected to pressurized supply lines 365, 366, 367, and 368, and further connected to the inlet injection port 134 of reactor 100 (i.e., via (126)) which is connected to the radial injection inlet 202 of the injection / bleed ring 110.

[0167] Sources of protective reagents / reactants (350)(369)(376)(385)

[0168] In some embodiments, one and / or more of the reactants and / or reagents listed below are used upstream, downstream, and / or inside the reactor of reaction (R)(140) and / or concentric protection zone ix(137)(138)(139): oxidizing agents (air, oxygen, hydrogen peroxide, ozone, permanganate, persulfate, and / or others), pH adjusting reagents (citric acid, acetic acid, sodium hydroxide, calcium hydroxide, potassium hydroxide, ammonium hydroxide, hydrochloric acid, magnesium hydroxide, sodium carbonate, lithium carbonate, potassium carbonate, sulfuric acid, nitric acid, Alcohols (ethanol, methanol, isopropyl alcohol, and / or others), subcritical water and / or supercritical water, supercritical carbon dioxide, carbon dioxide, steam, hydrogen, biogas, biodiesel, helium, argon, hydrogen, nitrogen, ammonia, methane, urea, surfactants (amphoteric, anionic, cationic, nonionic, amphoteric, gemini type), morpholine, cyclohexylamine, diethylaminoethanol, ethanolamines, monoethanolamine, methylamines, ethylamines, 3-methoxypropyl Amine, 2-aminoethoxyethanol, sodium sulfite, sodium bisulfite, sodium bisulfite, potassium ferrate, calcium sulfate, glycol, glycolic acid, diethylhydroxylamine (hydroxylamines), oleylpropylenediamine, orthophosphate, polyphosphate, zero-valent iron, aluminum hydroxide, aluminum sulfate, lithium aluminum hydride, sodium nitrite, sodium nitrate, ferric chloride, ferric sulfate, ferrous sulfate, sodium aluminate, activated carbon, aerogel, TFA, erythorbate, tetraacetylethyl Diamine, urea peroxide, potassium pyrophosphate, sodium tripolyphosphate, sodium hexametaphosphate, ammonium bifluoride, hydroxyacetic acid-formic acid, superoxide, phosphoric acid, non-FFP, potassium sulfite, peracetic acid, phenol, zinc and zinc compounds, refrigerants, triazole compounds, dihydrogen phosphate or trisodium phosphate, sodium borohydride, dichloromethane, permanganate, potassium ironate, hydrazine, carbohydrazide, sodium dithionite, sodium perborate, sodium percarbonate, sodium perphosphate, phosphates,Calcium polyphosphate, methyl ethyl ketoxime, phosphinocarboxylic acid, propylene glycol, phosphonates, aminotris-methylenephosphonic acid, 1-hydroxyethylidene-1,1-diphosphonic acid, phosphonobutane-1,2,4-tricarboxylic acid, polyaminopolyethermethylenephosphonate, acrylic acid and allyl-hydroxypropyl sulfonate ether, polyepoxysuccinic acid, ammonium persulfate, acrylic acid terpolymer, 2-acrylamide-2-methylpropylsulfonic acid, t-butyl Crylamide, ammonium acetate, fluorescein solvents, ionic salts, metal catalysts including iron, nickel, cobalt, palladium, aluminum, tin, titanium, and / or layered double hydroxides, nanofluidic mixtures (i.e., carrier fluids containing nanoparticles), eutectic mixtures and / or molten salt mixtures, molybdenum compounds, iron compounds, oxygen scavenger compounds, general stationary cleaning reagents, or other compounds that facilitate oxidation reactions, passivation and protection reactions, extraction reactions, reactions that suppress by-product formation, electrochemical reactions, or combinations thereof of organic compounds.

[0169] Referring to Figures 15, 9, 10, and 4, it is understood that in these illustrated embodiments, the replenishment supply unit 369 for the i1 reagent blend 137 is connected to a pressurized supply line 370, which in turn is connected to an i1 regeneration unit 371. The regeneration unit 371 also accepts an i1 recycle flow 372 as an inflow. The regenerated i1 effluent from 371 is connected to supply lines 373, 374, and 375, and also to the inlet injection port 134 of the reactor 100 (i.e., via 126), which is connected to the tangential injection inlet 204 of the injection / bleed ring 110. In some embodiments, the replenishment supply unit 376 for the reagent blend 138 is connected to a pressurized supply line 377, which in turn is connected to an i2 regeneration unit 378. The regeneration unit 378 also accepts an i2 recycle flow 379 as an inflow. The regenerated i2 effluent from 378 is connected to supply lines 380, 381, 382, ​​383, and 384, and also to the inlet injection port 134 of reactor 100 (i.e., via 126), which is connected to the tangential injection inlet 203 of the injection / bleeding ring 110. Referring to Figure 15, the replenishment supply unit 385 for the i3 reagent blend 139 is connected to supply line 386, which merges with the processed i3 reagent blend from line 387 at line 388, which is connected to the inlet injection port 134 of reactor 100. The i3 reagent blend 139 may not be directly connected to the injection / bleeding ring device 110, as described in Section 1, in which case a uniform annular chamber 280 separated along the tubular shell 105 may be formed, isolated from i1(137), i2(138), and R(40). The injection / bleeding device 110 supports the formation of a protective fluid barrier i3(139) by providing means 60g for fixing the solid liner 162, and isolates i3(139) from i2(138) and / or i1(137). The i3 blend 139 may be connected to 134 and is injected into separate homogeneous annular chambers at multiple locations along the axial length of the tubular shell.

[0170] In some embodiments, all injection and discharge lines of reactor 100 are pressurized to meet the reactor's operating conditions (i.e., above critical pressure). In some embodiments, multiple means may be used to pressurize the lines (e.g., a configuration in which a high-pressure pump is placed downstream of a low-pressure pump to function as a booster pump for multiple supply lines). In some embodiments, devices for inducing oscillating flow may be used in multiple injection and / or discharge lines.

[0171] In other embodiments, vibrations can be generated using devices such as pistons, bellows, diaphragms, syringes, or peristaltic pumps, or other devices. In such embodiments, vibrations can be generated by operating hydraulically controlled pistons located at both ends of the tubular reactor in opposite phases, or by using a pulsator pump and / or a hydraulic accumulator. To prevent cavitation or vaporization, a pulsation damper and back pressure regulator may be provided at the reactor outlet. The frequency and amplitude of the vibrations can improve the suspension and transportability of solids. In some embodiments, the tubular reactor may be operated alternately between the subcritical and supercritical regions based on pressure fluctuations by incorporating devices such as a flash tank and / or a steam trap. The tubular reactor may also be converted into an oscillating flow reactor for subcritical and supercritical water applications to improve mixing, heat transfer, residence time, mass transfer, and reduce solid / salt precipitation.

[0172] In addition to the reagent 350 described above, the reactor may be operated in gas-liquid segmented flow mode by injecting air or nitrogen, thereby improving particle transport as is commonly done in pharmaceutical applications and plug-flow crystallizers; or, by superimposing vibrations on the net flow of the reactor, the risk of blockage can be reduced and reactor volume and residence time can be separated. Hydrothermal reactor (100)

[0173] Embodiments of the hydrothermal reactor 100 may include an array of injection / bleed rings 110 (described in Section 1 and shown in Figures 1, 2, 3 and 3A-3H), which are supported along their axial length within a tubular shell 105 (described in Section 1 and shown in Figures 4-8B). As described in Section 2 and shown in Figures 9 to 11, embodiments of the injection / bleeding ring 110 may initiate, maintain, and / or transition the reaction 40 via radial injection 147 of reactants 348 and 349, and isolate the tubular shell 105 from the reaction 40 by forming a barrier including i1(137), i2(138), and / or i3(139) via tangential injection, and further allow bleeding / removal of fluid from the protective fluid barrier including the chemical reaction 40 and / or i1(137), i2(138), and / or i3(139) (as described in Sections 1 and 2). In some embodiments, at least two injection / bleeding ring devices 110 may be supported within the tubular shell 105. In some embodiments, at least one injection / bleeding device 110 is configured to start and / or maintain reaction 40, and at least one injection / bleeding device 110 is configured to transition and / or neutralize reaction 40. Each injection / bleeding device 110 may define a stage of reactor 100. Reactor (100) may have multiple stages, each stage may be operated under multiple conditions. In some embodiments, each injection / bleeding device 110 is supported within a tubular shell 105 by clamps and / or flange connections 125 (i.e., forming a modular reactor body). Each stage and / or modular section may be defined as Nx. Further details of reactor apparatus and methods are described elsewhere in this specification.

[0174] Hydrothermal reactor (100) / Injection / Bleeding ring 110 - Radial injection (348) (349) (140) (Burner)

[0175] In embodiments of the present invention, the fluid may be injected radially toward the central reaction zone (R) 40 from primary radial injectors (i.e., fluid outlets 112 and / or 112a) positioned around the inner surface of the injection / bleed ring 110i(Nx) to initiate / maintain / transition / control the reaction with organic compounds in the wastewater feed 348. Furthermore, in some embodiments, the fluid from the central reaction zone (R) 40 may be bled radially away from the reaction zone (not shown).

[0176] Embodiments of radial injection 147 may include wastewater feed 348 and oxidizer feed 349. In some embodiments, wastewater feed 348 may be mixed with co-fuel 359 to increase its calorific value. In some embodiments, the radial injection line may be switched to CIP mode to clean the inside of reactor 100. In some embodiments, the radial injection surface of the injection / bleeding apparatus is provided with a coating layer containing ceramic and / or metal oxides. In some embodiments, the coating layer contains inorganic deposits derived from components present in the feed waste. Components in the feed may coat the radial burner surface after injection, and this coating layer has insulating properties, thereby providing the function of protecting / isolating the apparatus from the thermal gradient. In some embodiments, the thickness of the coating layer on the burner is 0.002 inches to 0.015 inches.

[0177] In some embodiments, R40 is maintained under excess stoichiometric conditions, >600°C, and >22.1 MPa. In some embodiments, R40 is operated at >600°C by a controlled heating mechanism, such as direct injection of high-temperature SCW to heat the central reaction zone 40, or other methods known to those skilled in the art. In some embodiments, a finely dispersed mixture is important to improve the reaction surface area and promote complete mineralization of organic matter. In some embodiments, R40 is operated using a hydrothermal flame. A hydrothermal flame can provide a higher bulk temperature for the central reaction zone 40. The hydrothermal flame can be generated and maintained under SCWO conditions due to the excellent heat / mass transfer properties of SCW. The ignition temperature of the hydrothermal flame is approximately >400°C. In some embodiments, an ignition device may be used to assist in the transition of reactor operation from transient to steady-state operation and may be coupled to an injection / bleeding device. In some embodiments, a flame safety system, such as a flame safeguard, or similar means to assist in flame stability and operation control, may be used / coupled at multiple locations along the reactor. In some embodiments, multiple temperatures are maintained along the axial length of R(140), such as >374°C, >500°C, >600°C, >650°C, >800°C, >1,000°C, or >1,200°C. In some embodiments, reactor 100 has a modular section (Nx) using 110 to transition the temperature of R40 to <200°C, <300°C, <350°C, or <420°C. In some embodiments, the pressure of reactor 100 is maintained at >3,200 psig, >3,300 psig, >3,400 psig, >3,500 psig, >3,600 psig, or >4,000 psig by means known to those skilled in the art. In some embodiments, inorganic materials / salts / solids may be recovered at various stages of the reactor and / or process. In some embodiments, the residence time in the reaction zone 40 of reactor 100 is <5 seconds, <10 seconds, <30 seconds, <1 minute, or <5 minutes. In some embodiments, the residence time of the reactor is <10 seconds, <30 seconds, or <60 seconds.

[0178] Referring to Section 1, in one embodiment, the injection / bleeding device 110 of the reactor 100 includes auxiliary radial injectors for additional specific fluids, arranged circumferentially on the inner surface of the device 110, which are located at multiple longitudinal positions along the inner surface of 110 and are configured to inject fluid radially at multiple angles between the fluid outlet and the longitudinal axis 30. This is intended to provide auxiliary control over the radial and longitudinal fluid profiles in R40 (for example, to promote fluid flow and / or reaction, and / or to dilute / suppress fluid flow and / or reaction, including to function as a fluid damper).

[0179] In some embodiments, additional fluid outlets are provided along the inner surface of 110 above and / or below the wastewater feed and oxidizer outlets as auxiliary radial injectors, intended to dampen the reaction and / or provide auxiliary control over the reaction in the central reaction zone 40. Examples of fluids for damping the radial and / or longitudinal fluid profile 280 and / or the reaction include, but are not limited to, CO2, air, nitrogen, and / or chemical inhibitors. In some embodiments, CO2 is recirculated from the depressurization process 405 and injected to dampen the reaction. In some embodiments, in addition to dampers for a given module section, the concept of damping may also apply to the entire reactor 100, in which case multiple radial injection points along the axial length of reactor 100 may be equipped with damper fluids, but the wastewater feed and / or oxidizer are not injected.

[0180] In some embodiments relating to the auxiliary radial injector, additional fluid outlets are positioned along the inner surface of 110, above and / or below the wastewater feed and oxidizer outlets, for the purpose of accelerating the reaction and / or providing auxiliary control over the reaction in the central reaction zone 40. The principle applied is such that the oxidizer is injected in an "overfire" manner. In some embodiments, the application of the overfire oxidizer includes 80–95% of the stoichiometric COD requirement injected from the primary radial injector and 5–20% of the stoichiometric COD requirement injected from the auxiliary radial injector. In some embodiments, the application of the overfire oxidizer includes at least 95% of the stoichiometric COD requirement injected from the primary radial injector and 5–30% of the stoichiometric COD requirement injected from the auxiliary radial injector. In some embodiments, in addition to an overfire oxidizer for a given module section, the concept of an overfire oxidizer may also be applied to the entire reactor 100, in which case multiple radial injection points along the axial length of the reactor 100 may be filled with the overfire oxidizer fluid, and no wastewater feed is injected. Fluids for improving the radial and / or longitudinal profile by the overfire method include, but are not limited to, hydrogen peroxide, oxygen, air, chemical initiators, and / or chemical activators.

[0181] Hydrothermal reactor (100) / Injection / Bleed ring 110 - Tangential injection and bleed (350) (137) (138) (139)

[0182] In embodiments of the present invention, the fluids i1(137) and / or i2(138) may be injected tangentially toward Nx+1 from fluid outlets 113 and 114 located circumferentially on the injection / bleed ring 110(Nx). The fluid i3(139) may be coupled to 134 and injected into separate, homogeneous annular chambers 280 at multiple locations along the axial length of the tubular shell 105, isolated from i1(137) and / or i2(138). Referring to Section 2 and Figures 9 to 11, in some embodiments the combination of concentric protective zones 350 includes ii. In some embodiments ii may be present, but the range of action of ii may be extended to additional i categories without providing an additional fluid layer, depending on the thermal, chemical and / or physical fluid properties of the fluids. In some embodiments the combination of concentric protective zones 350 includes iii.

[0183] Referring to Figures 9 to 11, in some embodiments, i1(137) represents an initiator, i2(138) represents an inhibitor, and i3(139) represents an insulator. In some embodiments, the order / arrangement of each zone may differ, and any combination may exist. In some embodiments, the liner may separate any ix. In some embodiments, the liner may be porous. In some embodiments, the liner may be solid. In some embodiments, the liner is non-pressure resistant. In some embodiments, the pressure vessel 105 is a pressure resistant structure and surrounds ix and R40. In some embodiments, one or more of i1(137), i2(138), and / or i3(139) may not be present in the reactor. In some embodiments, i1(137), i2(138), and / or i3(139) may have thermal, chemical, and / or physical fluid properties corresponding to one or more of the concentric zone category iii.

[0184] In some embodiments, R40 may be surrounded by i1(137) which includes a mixture 350 containing at least SCW at a different temperature from R40. In some embodiments, i1(137) includes additional reactants / reagents selected from a protective reagent / reactant source (350). In some embodiments, i1(137) includes an oxidizing agent. In some embodiments, i1(137) includes a pH adjusting reagent. In some embodiments, the reagent is added to i1(137) to adjust the pH to >7, >8, >8.5, >9, >10, or >11. In some embodiments, the ORP of i1(137) is >0mV, >50mV, >100mV, >150mV, >200mV, >300mV, >400mV, or >500mV. In some embodiments, i1(137) is maintained at a temperature of <650°C, <420°C, or <374°C. In some embodiments, the oxidizing agent concentration of i1(137) is maintained at <30% by weight, <20% by weight, <10% by weight, <5% by weight, <2% by weight, or <1% by weight. In some embodiments, reactant / reagent 350 is added to i1(137) to precipitate the salts diffusing into the region, allowing for recovery and / or treatment. In some embodiments, i1(137) comprises a molten salt mixture of reactant / reagent 350 using hydroxides, carbonates, nitrates, and / or eutectic mixtures. In some embodiments, i1(137) comprises a molten salt mixture (i.e., molten salt oxidation) using a eutectic mixture containing hydroxides, carbonates, nitrates, and / or oxidizing agents. R40 is maintained under (excess) stoichiometric conditions and at high temperatures (>600-650°C), while i1(137) is maintained at lower temperatures, providing adiabatic properties, facilitating reaction kinetics, and potentially acting as a buffer layer. While the majority of the oxidation reaction occurs within the central reaction zone (140), a low concentration of oxidizing agent can be maintained in i1(137) to ensure complete mineralization of organic matter upon diffusion into region (137). Depending on the characteristics of the wastewater feedstock, i1(137) may also contain a mixture that catalyzes the reaction and retains inorganic components in solution by influencing solubility.Since the axial fluid flow in the central reaction zone (140) is typically upward and the axial fluid flow in i1 (137) is typically downward, a counterflow fluid profile is formed. Referring to Figures 15, 4, 3A, and 6, i1 (137) may be recovered from the fluid inlet 206 of the injection / bleed ring 110 and connected (via 126, 215, and 116) to the discharge port 135 of the reactor (100), which is connected to bleed lines 389, 390, 391, and 372.

[0185] In some embodiments, i1(137) may be surrounded by i2(138), which contains a mixture 350 containing at least subcritical water. In some embodiments, i2(138) contains additional reactants / reagents selected from the protective reagent / reactant source 350. In some embodiments, an oxidizing agent reagent is added to i2(138) to maintain a low residual oxygen concentration. In some embodiments, the residual oxygen includes <1 ppm, <500 ppb, <250 ppb, <100 ppb, <10 ppb, or <7 ppb. In some embodiments, the ORP of i2(138) is <0 mV, <-50 mV, <-100 mV, <-150 mV, <-200 mV, <-300 mV, <-400 mV, or <-500 mV. In some embodiments, i2(138) contains a pH adjusting reagent. In some embodiments, i2(138) includes a reactant / reagent that decomposes to produce a pH-adjusting reagent. In some embodiments, i2(138) includes a reagent that has the function of suppressing the oxidation reaction at 40 and does not produce soluble solids. In some embodiments, i2(138) includes a reagent that has the function of suppressing the oxidation reaction at 40 and produces soluble solids. In some embodiments, i2(138) includes a pH-adjusting reagent that raises the pH within i2(138) to >8, >9, >10, >11, or >12. In some embodiments, a porous liner separates i1(137) and i2(138). In some embodiments, i2(138) is maintained at a temperature of <374°C, <350°C, <300°C, <250°C, or <200°C. The i2 protection zone may contain a scavenger to suppress exothermic reactions along the porous liner, a reagent to increase the pH to prevent corrosion of the porous liner and pressure vessel, to improve heat transfer, and / or to reverse the solubility of an inorganic compound if it diffuses through i1(137). Referring to Figures 15, 4, 3A, and 6, i2(138) may be recovered from the fluid inlet 205 of the injection / bleed ring 110 and connected (via 126, 214, 115) to the discharge port 135 of the reactor 100, which is connected to bleed lines 392, 393, 394, 395, and 379.

[0186] In some embodiments, i2(138) may be surrounded by i3(139) containing a fluid having a low thermal conductivity. In some embodiments, i3(139) contains a reactant / reagent selected from a protective reagent / reactant source 350. In some embodiments, the thermal conductivity of i3(139) is <1 W / (m*K), <0.75 W / (m*K), <0.5 W / (m*K), <0.25 W / (m*K), <0.15 W / (m*K), <0.10 W / (m*K), <0.075 W / (m*K), or <0.05 W / (m*K). In some embodiments, the thermal conductivity of i3(139) is <0.05 W / (m*K). In some embodiments, a solid liner separates i2(138) and i3(139). In some embodiments, i3(139) is maintained at a temperature of <374°C, <350°C, <300°C, <250°C, <200°C, <150°C, <100°C, or <50°C. In some embodiments, i3 is maintained at a temperature of <200°C. In some embodiments, a solid material having a thermal conductivity of <0.5 W / (m*K), <0.25 W / (m*K), <0.15 W / (m*K), <0.10 W / (m*K), <0.075 W / (m*K), or <0.05 W / (m*K) may be used to line the pressure vessel 105. In some embodiments, i3(139) is located within a uniform isolation chamber 280 along the entire length of the longitudinal axis of 105. Instead of injecting or bleeding this fluid from each Nx, the fluid may flow continuously along the length of the longitudinal axis (for example, from Nx-1 to Nx, and then to Nx+1). This fluid may be injected and recovered at any position along the axial length of the shell through perforated injection / discharge ports 134, 135. This protective zone is preferably isolated from other protective zones by a solid liner. Referring to Figures 15 and 6, i3 (139) is discharged from the discharge port 135 of the reactor 100, which is connected to the bleed line 396. The bleed line 396 is connected to the i3 processing unit 397, and its i3 processing effluent is connected to line 387.

[0187] In some embodiments, one or more of the reactor protective fluid reagents ix(137)(138)(139) are maintained at temperatures of <800°C, <650°C, <420°C, <374°C, <350°C, <300°C, <250°C, <200°C, <150°C, and / or <100°C. In some embodiments, one or more of the reactor's protective fluid reagents ix(137)(138)(139) are maintained for residence times of >2 seconds, >10 seconds, >30 seconds, >60 seconds, >2 minutes, >5 minutes, >7 minutes, >10 minutes, >15 minutes, >20 minutes, >25 minutes, >30 minutes, >35 minutes, >45 minutes, >60 minutes, >120 minutes, >180 minutes, >300 minutes, >600 minutes, >1,200 minutes, >1,800 minutes, or >2,400 minutes. Consideration should be given in the reactor design and / or assembly to appropriately address the temperature difference between the reaction zone and the protective fluid barrier to prevent under- or over-condensation and to reduce / eliminate corresponding pressure fluctuations (i.e., temperature differences can lead to changes in fluid properties, and this should be considered in the pressure vessel design).

[0188] It should be understood that the regeneration treatment options for each concentric protection zone (ix)(137)(138)(139) depend on their thermal, physical, and / or chemical properties as they flow out of the reactor. Various processing options include, but are not limited to, flocculation, filtration, adsorption (e.g., activated carbon, ion exchange, etc.), membrane separation (e.g., reverse osmosis, nanofiltration, ultrafiltration, electrodeionization), degassing, chemical precipitation, disinfection, aeration, pH adjustment (i.e., raising or lowering), temperature adjustment (i.e., heating or cooling), foam fractionation, clarification, dilution, pressure swing adsorption, UV irradiation, gravity sedimentation, centrifugal sedimentation, dissolved gas flotation separation, thickening, wet washing, mechanical dehydration, absorption processes, electrochemical processes, liquid-liquid extraction processes, solid-liquid extraction processes, chemical catalyst regeneration, crystallization, magnetic field treatment, chemical oxidation, chemical reduction, oxidizing agent / oxygen scavenging, natural treatment systems, UV treatment, distillation, stripping, humidity / gas drying control, moisture removal, metal recovery, or combinations thereof.

[0189] In some embodiments, one or more of the recycling ratios (as a percentage of the total volumetric flow rate required for each protective barrier in the reactor) of the concentric protection zones (ix)(137)(138)(139) include >99%, >95%, >90%, >80%, >70%, >60%, >50%, and / or >140% of the flow rate returned to each concentric protection zone in the reactor. In some embodiments, depending on changes in reactor operating conditions, at least a portion of the recirculated flow and / or replenishment supply of the concentric zones may be mixed with another concentric protection zone to improve protective performance. In some embodiments, one or more of the concentric protection zones (ix)(137)(138)(139) may be partially or completely recirculated to multiple locations in the system, such as wastewater inflow, brine, distillate, and / or gas-liquid discharge flow, and / or subsequent treatment processes.

[0190] For a given combination of concentric protective zones described herein, Figure 19 shows the radial temperature as a function of the normalized radial position within the reactor with respect to a hypothetical rapid rise in the reaction zone temperature and the corresponding pressure vessel temperature. In this scenario, the steady-state reaction temperature is set as an independent variable based on the temperature and residence time requirements for the persistent organic contaminant in question. For illustrative purposes, a reaction zone temperature of >600°C under appropriate stoichiometric conditions can ensure the effective mineralization of persistent organic compounds such as sulfonated PFAS compounds or other chemical species. For further illustrative purposes, the combination of concentric protective zones includes chemical species such as supercritical water, oxidizing agents, subcritical water, nitrogen, pH adjusting reagents, and common reagents that decompose to produce inhibitors.

[0191] Hydrothermal reactor (100) / Tubular shell assembly

[0192] In some embodiments, the elements constituting the tubular shell assembly may include an injection / bleeding device 110, an inlet 134, and an outlet 135. In one aspect of the present invention described herein, the tubular shell in an SCWO application includes the elements described in Section 1, which will be described for convenience with reference to Section 1 and Figure 15.

[0193] In some embodiments, the tubular shell may include a hollow tubular pressure vessel. The dimensions and thickness of the tubular shell must be sufficient for the operating conditions and must conform to all relevant standards (e.g., ASME pressure vessel standards such as ASME Section VIII, Division 1, and / or ASME Power Piping Code B31.1). In some embodiments, the tubular shell includes Alloy 625, Hastelloy C-276, austenitic stainless steel, ferritic-martensitic steel, titanium, and / or other materials known to those skilled in the art. In some embodiments, the outer surface of the pressure vessel is maintained at a temperature of <400°C, <350°C, <300°C, <250°C, <200°C, <150°C, <100°C, or <50°C). In some embodiments, the outer surface of the pressure vessel is maintained at a temperature of <200°C. Liners arranged along the length of the reactor may include stainless steel, titanium, ceramics, Alloy 625, or other materials. In some embodiments, the pressure vessel and / or related materials include Alloy 625. In some embodiments, the pressure vessel and / or related materials include 316 stainless steel (TP316). In some embodiments, the thickness of the pressure vessel is defined by the ASME pressure vessel standard. In some embodiments, the nominal diameter of the pressure vessel is >1 inch, >2 inches, >3 inches, >4 inches, >6 inches, >8 inches, >12 inches, >16 inches, >20 inches, or >24 inches. In some embodiments, insulation material may be fixed to the outer surface of the pressure vessel.

[0194] In some embodiments, the modular reactor is housed in a protective container (e.g., a shipping container). In some embodiments, the reactor is housed in a (typical) shipping container (e.g., 20 feet x 8 feet x 8 feet in size). In some embodiments, the reactor is housed in a Lexan TMAlternatively, it may be surrounded by a pressure relief panel consisting of other similar panels known to those skilled in the art. In some embodiments, all enclosures are equipped with vents and / or pressure relief devices relative to the protective vessel enclosure for the reactor. In some embodiments, the length of the pressure vessel is <8 feet, <6 feet, <5 feet, <4 feet, <3 feet, <2 feet, or <1 foot. In some embodiments, the length of the pressure vessel is <6 feet. In some embodiments, the modular reactor is portable and transported from place to place. In some embodiments, the modular reactor is fixed and operated in a predetermined location for a long period of time. In some embodiments, the length of the pressure vessel is >6 feet, >8 feet, >10 feet, >12 feet, >16 feet, >20 feet, <24 feet, or >30 feet.

[0195] Referring to Figure 15, in one embodiment, the injection / bleed ring device 110 has a clamp and / or flange connection (125) (for example, Grayloc) as described in Section 1. TM ) is supported within the tubular shell 105. In some embodiments, the tubular shell 105 of the reactor has an open inlet end and an open outlet end, representing a flow-through embodiment of the reactor with an injection / bleeding device 110 (not shown in Figure 15) fixed along the axial length of the tubular shell 105. In some embodiments, the tubular shell may be oriented horizontally. In some embodiments, the tubular shell is oriented vertically (see Figure 15).

[0196] Referring to Figures 15 and 6, in the illustrated embodiment, the tubular shell 105 is oriented vertically and closed at the top 100t and bottom 100b (e.g., by blind flanges or other connecting means), except for the inlet 134 and / or outlet 135 (e.g., 136). Referring to Figure 15, the reactor (100) is divided into several stages based on the arrangement of the injection / bleed ring device 110. Stage 0 is located at the top 110t of the reactor and is shown as 398, Stage 1 is 399, Stage 2 is 400, Stage 3 is 401, and Stage 4 is located at the bottom 110b and is shown as 402. Although five stages are shown in Figure 15, in some embodiments, there may be multiple stages operating under different conditions. Discharge ports 135 (e.g., 136) are provided at Stage 0 (398) for discharging distillate (352) and at Stage 4 (402) for discharging brine (353). Stage 0 (398) operates with an injection ring device 110 located at the top and a discharge port 135 on the longitudinal axis, as described in Section 1. Stage 0 (398) is configured to perform circumferential injection of ix (138). Stage 1 (399) is configured to perform circumferential bleeding and injection of ix (137)(138) and radial injection of the reactants. Radial injection of the reactants in Stage 1 may form a central reaction zone 40 at a lower temperature than Stage 2 (400) and may function as a temperature transition zone. In Stage 2 (400), radial injection may occur under conditions where the temperature of the central reaction 40 is >600~650°C. Stage 3 (401) is configured to perform both radial injection of the reactants and circumferential bleeding and injection of ix (138) (for example, functioning as a neutralization zone and / or a quenching / cooling zone). The radial injection of the response material in stage 3 (401) may form a central reaction zone 40 that is colder than that of stage 2 (400) and may function as a temperature transition zone. Stage 4 (402) is configured to perform circumferential bleeding of ix (138) (e.g., for quenching and / or blowdown of the brine).The solid liner 162 may be attached to the injection / bleeding device 110 along the length of the tubular shell 105 to separate i3(139) from i2(138). The porous liner 162a may be fixed on the injection / bleeding device 110 along the length of the tubular shell 105 and positioned between i1(137) and i2(138). The porous liners 162a fixed to stages 3(401) and 4(402) may be positioned at an angle such that the flow is directed toward the discharge port 135 (e.g., 136) of the brine 353.

[0197] In an alternative embodiment, with respect to 110 fixed at (398), instead of radial injection, a plurality of primary longitudinal injectors can be positioned on the top of reactor 100 and along the centerline of the longitudinal axis, as shown in 136 in Figure 6, to inject wastewater 348, 359 and oxidizer 349 to form a central reaction zone along the centerline of the longitudinal axis. In this embodiment, the injectors at 398 include coaxial injectors or a plurality of other injectors. In some embodiments, cooling liners are fixed to the surface of 110 and / or a coating layer is applied to reduce the thermal gradient near the injectors and / or injection / bleeding device 110. Thus, instead of discharge at 398, distillates may be discharged from a plurality of positions along the axial length of reactor 100.

[0198] In alternative embodiments relating to 110 fixed to 402, instead of a neutralization zone and radial injection, multiple primary longitudinal injectors can be positioned at the bottom of reactor 100 and along the centerline of the longitudinal axis, as shown in 136 in Figure 6, to inject wastewater 348, 359 and oxidizer 349 to form a central reaction zone along the centerline of the longitudinal axis. In this embodiment, the injectors at 402 include coaxial injectors or multiple other injectors. In some embodiments, cooling liners are fixed to the surface of 110 and / or a coating layer is applied to reduce the thermal gradient near the injectors and / or injection / bleeding device 110. In some embodiments, when the injectors are positioned at the bottom of the reactor, the porous liner 162a is positioned vertically and not inclined between 401 and 402. Thus, instead of discharge at 402, brine 353 may be discharged from multiple locations along the axial length of reactor 100.

[0199] In some embodiments, the hydrothermal reactor is operated continuously. In some embodiments, the hydrothermal reactor is operated as a batch process. In some embodiments, multiple hydrothermal reactors are operated in parallel, as shown in Figure 16, to ensure a certain range of turndown capability and redundancy. In some embodiments, multiple hydrothermal reactors are operated in series. In some embodiments, multiple hydrothermal reactors are operated in series, with each reactor operating under different thermal and / or reaction conditions. In some embodiments, when multiple hydrothermal reactors are operated in series, at least one reactor may operate under oxidizing conditions and at least one reactor may operate under reducing conditions across multiple temperature conditions. In some embodiments, multiple hydrothermal reactors are operated in parallel, supplying effluent to a common processing module for solids treatment, etc., as shown in Figures 14C and 14D. In some embodiments, the flow-through processing capacity per module is <1 gph, >1 gph, >5 gph, >10 gph, >20 gph, >50 gph, >75 gph, >100 gph, >200 gph, >300 gph, >500 gph, >1,000 gph, or >1,250 gph.

[0200] Referring to Figure 15, even if not shown, all piping and reactors should be configured to include appropriate valves, pressure relief devices, or other auxiliary equipment. Where necessary, flush tanks, check valves, solenoid valves, safety valves, block-and-bleed valves for system isolation, and / or steam traps should also be considered.

[0201] Referring to Section 1, the reactor is measured by pressure, temperature, pH, conductivity, cation conductivity, oxidation-reduction potential (ORP), chemical oxygen demand (COD), total organic carbon (TOC), flow rate, water level / fluid level, dissolved oxygen (DO), iron (Fe), sodium (Na) + The monitoring device may include sensors for Ca, Mg, chloride, sulfate, alkalinity, silica, phosphate, ammonia, moisture, ultrasound, H2S, CO, NOx, SOx, concentrations of various components, or other sensors known to those skilled in the art.

[0202] Once data is collected and stored from the monitoring device, feedback is sent to various control schemes, and the injection / bleed ring 110 of reactor 100 responds to the feedback by changing the operating conditions to maintain the controlled state. For example, the various control schemes include, but are not limited to, the following: The COD or TOC can be monitored at 352 and / or the CO concentration in the gas effluent from 405, and if they increase, the oxidizer concentration can be increased by the operating valve at supply line (365) and / or the waste supply flow rate can be reduced by the operating valve at supply line (360). The temperature difference in ix can be monitored, and the flow rate of i1 in supply lines (373), (374), (375), i2 in supply lines (380), (381), (382), (383), (384), and / or i3 in supply line 388 can be adjusted to reduce the temperature of the pressure vessel. The conductivity or cation conductivity can be monitored at 353, and the flow rate (i.e., blowdown) from the discharge port 135 (e.g., 136) at 402 can be increased or decreased to maintain an appropriate concentration cycle. The ORP can be monitored for i1(137) on supply line 373, and the response can be adjusted by adjusting the reagent flow rate in supply line 370 or recirculation line (372). The pH of i2(138) on supply line 380 can be monitored, and the reagent flow rate in supply line 377 or recirculation line 379 can be adjusted to respond. The concentrations of various inorganic substances and / or cation conductivity can be monitored at the bleed lines (389)(390)(391), the degree of inherent mixing and / or diffusion of the salt between the central reaction zone 40 and i1(137) can be evaluated, and the response can be adjusted by adjusting the bleed flow rate of i1(137) from the bleed lines (389)(390)(391).

[0203] In some embodiments, the pressure difference (DP) may be monitored during operation, and if the DP rises to a predetermined value, CIP is initiated. In such embodiments, the film-forming zone is switched to CIP mode, in which CIP mode it can be operated to discharge an appropriate reagent solution (e.g., pH adjusting solution, or cold DI water wash) to wash the liner or pressure vessel and facilitate the removal of deposits / salts from the walls exposed to the reaction zone. During these CIP washes, the reagent solution flows down through the reaction zone by gravity and may be collected at the bottom of the reactor for further processing, or sent to a separate modular pressure vessel as described below. After the CIP is complete, the film-forming zone returns to its original operating state. The bleed / injection equipment / system shall include a general set of equipment such as control valves, piping, shut-off valves and check valves, and appropriate instrumentation.

[0204] Many other control strategies are possible, but they will not be described in detail here. In some embodiments, the control logic further includes emergency stop, system monitoring and alarm, safety interlock strategies, and methods for parameter setting.

[0205] Reactor effluent / distillate

[0206] In some embodiments, the treated effluent discharged from the top of reactor 100 includes distillate 352. In some embodiments, the treated effluent may be discharged from multiple locations along the axial length of reactor 100. At some locations, distillate 352 may be discharged from the bottom of the reactor via a discharge port 135 located between 401 and 402, and may be discharged through the solid liner 162 and the porous liner 162a. In some embodiments, if distillate 352 is discharged from the bottom of the reactor or from multiple locations along the axial length of reactor 100, stage 0 (398) includes radial and / or longitudinal injection of quenching water to reduce the temperature at the top of the reactor.

[0207] In some embodiments, heat may be recovered from the distillate via 358 prior to depressurization (i.e., gas-liquid separation) 405, further processing, and / or discharge 406. In some embodiments, additives (e.g., sodium hydroxide or other reagents for neutralizing acidic species) may be injected to further neutralize the effluent. In some embodiments, the reactor effluent 352 is depressurized 405 by a back pressure regulator, a plurality of orifice plates, a capillary coil, an expansion turbine and / or a heat / energy recovery cycle, a throttle valve, or other means known to those skilled in the art. After depressurization, the liquid and gas phases are separated in a separation vessel (not shown). In some embodiments, the gases released during and / or after the gas-liquid separation process are discharged after scrubbing and monitoring. In some embodiments, at any location downstream of 352, the treated effluent may be recycled for reuse in the process at a plurality of locations along each fluid flow path. The depressurization, gas-liquid separation, and discharge processes of the treated effluent are generally well established in the prior art and are not required to be described in detail in the disclosure of the present invention.

[0208] Reactor effluent / brine

[0209] In some embodiments, the treated effluent discharged from the bottom of the reactor 100 includes brine 353. In some embodiments, the brine 353 is optionally treated 407 before and / or after quenching (i.e., cooling). In some embodiments, heat may be recovered from the brine via 407 prior to depressurization (i.e., gas-liquid separation) 408 and / or discharge 406. In some embodiments, the reactor effluent 353 is depressurized 408 by a back pressure regulator, multiple orifice plates, capillary coils, expansion turbine and / or heat / energy recovery cycle, throttle valve, or other means. In some embodiments, the brine 353 is depressurized 408 by multiple orifice plates and / or capillary coils. In some embodiments, the gas discharged during and / or after the gas-liquid separation process is discharged after scrubbing and monitoring. In some embodiments, heat may be recovered during the treatment 407. In some embodiments, the brine 353 does not require treatment 407. In some embodiments, the brine 353 merges with the distillate 352 at multiple locations along the discharge line. In some embodiments, the brine 353 may be partially or completely recirculated at multiple locations along the fluid flow path (e.g., returned to the wastewater inlet).

[0210] Some persistent organic compounds and / or salts or other solids may require additional processing. Examples of solids include, but are not limited to, salts, sediments, precipitates, activated carbon, ion exchange resins, or other contaminating solids. In some embodiments of the present invention, a separate modular compartment located at the bottom of the reactor may be included, as shown in Figure 17, or a separate, dedicated modular pressure vessel may be included, as shown in Figure 14C, to allow for the recovery and / or addition of organic contaminating solids (e.g., from CIP or other processes, depending on the reaction and conditions). This separate compartment or vessel may be maintained under either supercritical or subcritical conditions, depending on the operating conditions of the reactor. The compartment or vessel may have an extended residence time and function similarly to a continuous stirred tank reactor (CSTR) operated under high temperature (>100°C) and high pressure (>200 psi), as shown in Figure 14C. In this case, the addition of reagents 350, 349 accelerates the decomposition of organic compounds in the solids (if necessary). Alternatively, the processing module may function as a sedimentation process, as shown in Figure 14D. The solids may fall from the reaction zone 40, or be transported separately to the solids processing module during the regeneration of ix or from other processing steps. In the embodiment shown in Figure 14D, a fume tubing may be provided, which may be operable to promote both sedimentation and recirculation flow characteristics within the container. A flow control valve may recirculate a portion of the effluent / mixture into the reaction zone 40 or the processing module to ensure additional residence time and continuous processing 355, or discharge it as further processing 353. Mineralization may be promoted and DRE improved by adding reagents 349, 350 to the recirculation line.

[0211] After an appropriate residence time within the reactor module, the solid material can be recovered from the separate compartment or container and / or appropriately discharged from the bottom of the module for further processing (depending on process effluent / discharge / project objective requirements). For example, if pH adjustment is performed to promote the mineralization of organic matter through CIP implementation and / or DRE improvement, the pH can be returned to neutral at the bottom of the module before rapid cooling and depressurization of the system. This improves the fluid flow characteristics and / or meets discharge requirements.

[0212] The solids reactor of the present invention may be provided in a stepwise configuration, in which multiple reaction zone-based modules are stacked on top of a solids processing module (stage 1), and the effluent from stage 1 flows to another group of modules (stage 2) before solids processing. Additional solids from other processes may be introduced into a dedicated pressure vessel for solids processing. The pressure vessel may have a cylindrical shape and may function similarly to a CSTR. It may also include or not include concentric ring regions having zones for oxidizers and / or reactants. A mixer located in the center of the vessel may be provided to facilitate mixing as an alternative to recirculation. The vessel may have dimensions designed to ensure an appropriate residence time and may be equipped with all necessary auxiliary equipment.

[0213] In some embodiments, particularly under supercritical water conditions, each module section may be provided with a permeable liner at its bottom to allow for the recovery of salts based on the pore size of the liner. In a modular reactor having multiple sections, each section may have different operating conditions and may have one or more permeable liners with different pore sizes to selectively recover various salts based on particle size. Salts may be recovered on each liner and may be removed during system maintenance to recover specific salts. In some embodiments, reactants are introduced at multiple stages of the reactor to precipitate and recover salts such as nutrients or other compounds. Section 4 Hydrothermal reactors and protection methods for subcritical operation

[0214] The present invention is not intended to be limited to specific operating conditions and / or chemical reactions. For illustrative and explanatory purposes only, and without limitation, one embodiment of the apparatus of the present invention (including any disclosures described in Section 1), a protection method (including any disclosures described in Section 2), and a high-pressure, high-temperature hydrothermal treatment application (including any disclosures described in Section 3) is described in this Section 4 based on a central reaction zone 40 under subcritical conditions for mineralizing an organic compound in the presence of an inorganic compound.

[0215] In this exemplary embodiment, Figure 12B shows a general process flow diagram for the mineralization of an organic compound in the presence of an inorganic compound in waste (e.g., wastewater for illustrative purposes), with the reaction proceeding under subcritical conditions. The general process flow of the reactor apparatus and method may be configured such that wastewater 348, reactants 349, and protective fluid reagent 350 are supplied to the reactor 100 under pressurization. The wastewater and reactants are maintained for an appropriate residence time under operating conditions for the reaction, and the treated reaction byproducts are quenched, further treated, and depressurized (i.e., gas-liquid separation) before further treatment and / or discharge. The protective fluid reagent 350 is injected into the reactor 100 under pressurization, maintained for an appropriate residence time to form a concentric protective zone and provide a protective fluid barrier, and then may be bled out of the protective zone and treated (354) (i.e., regenerated), and further recirculated (355) to the reactor 100. In some embodiments, solid byproducts may be separated and / or treated before, during, and / or after depressurization.

[0216] For illustrative purposes, in this embodiment, Figure 15 can be similarly used to explain a subcritical hydrothermal treatment application in which the temperature and pressure of the central reaction zone are maintained under subcritical operating conditions.

[0217] In some embodiments, multiple reactors are used in series, with at least one reactor operating under predetermined reactor conditions, followed by at least one other reactor operating under different conditions. In some embodiments, reactants / reagents may be injected between each reactor in series to transition the reactor operating conditions. In some embodiments, the injection / bleed ring device may operate under different reaction conditions within a single reactor apparatus. In some embodiments, the reactor effluent maintains its pressure before being introduced into other reactors operating in series. In some embodiments, the reactor effluent may be depressurized and then repressurized before being introduced into other reactors operating in series.

[0218] Similar to Section 3, the waste / wastewater 348 may be any source containing organic and / or inorganic compounds. In some embodiments, the hydrothermal reactor carries out a chemical reaction that defluorinates (i.e., breaks at least one carbon-fluorine bond) and / or mineralizes (i.e., the compound contains at least one carbon-fluorine bond) the PFAS. In some embodiments, the wastewater 348 is optionally pre-treated 356 before being introduced into the hydrothermal reactor 100 for the chemical reaction. In some embodiments, the wastewater 348 is optionally pre-heated 357 before being introduced into the reactor 100. In some embodiments, equipment for inducing oscillating flow may be used in multiple injection lines and / or discharge lines. In some embodiments, equipment means for operating in gas-liquid segmented flow mode may be connected to the reactor and / or any inlet and / or outlet lines.

[0219] In some embodiments, the injection / bleeding device 110 of the reactor 100 includes auxiliary radial injectors for additional specific fluids, arranged circumferentially on the inner surface of the device 110, which are located at multiple longitudinal positions along the inner surface of 110 and are configured to inject fluid radially at multiple angles between the fluid outlet and the longitudinal axis 30. This is intended to provide auxiliary control over the radial and longitudinal fluid profiles in R40 (for example, to promote fluid flow and / or reaction, and / or to dilute / suppress fluid flow and / or reaction, including acting as a fluid damper).

[0220] Referring to Figure 15, in this embodiment, the reactants (e.g., oxidizing agents) in the central reaction zone R may include or be replaced by several other reagents / reactants for radial injection into R. In some embodiments, R is maintained under alkaline conditions. In some embodiments, reagents are radially injected into R to adjust the pH to >7, >8, >8.5, >9, >10, >11, or >12. In some embodiments, R contains reactants / reagents that decompose to become pH-adjusting reagents. In some embodiments, R contains a reducing reagent in at least one reactor and / or injection / bleeding ring module section. In some embodiments, the reducing agent may include zero-valent iron. In some embodiments, R contains an oxidizing reagent in at least one reactor and / or injection / bleeding ring module section. In some embodiments, reducing conditions precede oxidizing conditions. In some embodiments, oxidizing conditions precede reducing conditions. In some embodiments, an oxygen scavenger is injected into the waste feed before the reactor. In some embodiments, R comprises a reagent that functions as an oxygen scavenger that does not produce dissolved solids. In some embodiments, R comprises a reagent that functions as an oxygen scavenger that produces dissolved solids. In some embodiments, the ORP of R is <0mV, <-50mV, <-10mV, <-150mV, <-200mV, <-300mV, <-400mV, or <-500mV. In some embodiments, the residence time in the reaction zone 140 of reactor 100 is <5 seconds, <10 seconds, <30 seconds, <1 minute, <5 minutes, <30 minutes, <60 minutes, <120 minutes, <180 minutes, <240 minutes, <300 minutes, <360 minutes, <420 minutes, or <600 minutes under conditions where ORP is <0 mV, <-50 mV, <-100 mV, <-150 mV, <-200 mV, <-300 mV, <-400 mV, or <-500 mV. After the reduction conditions in some embodiments, R may transition to oxidation conditions by radial injection of an oxidizing agent by an injection / bleeding device. In some embodiments, a high concentration of the oxidizing agent is maintained at R. In some embodiments, the oxidizing agent concentration in R is <1% by weight, >1% by weight, >5% by weight, >10% by weight, >15% by weight, or >20% by weight.In some embodiments, the residence time in the reaction zone 40 of reactor 100 under oxidative conditions is <5 seconds, <10 seconds, <30 seconds, <1 minute, <5 minutes, <30 minutes, <60 minutes, <120 minutes, <180 minutes, <240 minutes, <300 minutes, <360 minutes, <420 minutes, or <600 minutes. In some embodiments, the reactants may be preheated to >100°C, >200°C, >300°C, or >350°C. Since some recalcitrant organic compounds may decompose more readily under reducing conditions than under oxidative conditions, both conditions may be considered for R. For reactions involving exothermic autocatalytic conditions (e.g., oxidative and alkaline conditions), it is important to exercise caution as enhanced thermal control and monitoring may be necessary.

[0221] Referring to Figure 15, in this embodiment, the reagents / reactants in the concentric protection zone may include or be replaced by multiple other reagents / reactants. In some embodiments, i1(137) represents an initiator, i2(138) represents an inhibitor, and i3(139) represents an insulating agent. In some embodiments, the order / arrangement of each zone may differ, and any combination may exist. In some embodiments, the liner may separate any ix. In some embodiments, the liner may be porous. In some embodiments, the liner may be solid. In some embodiments, the liner is non-pressure resistant. In some embodiments, the pressure vessel 105 is a pressure resistant structure and surrounds ix and R40. In some embodiments, one or more of i1(137), i2(138), and / or i3(139) may not be present in the reactor. In some embodiments, i1(137), i2(138), and / or i3(139) may have thermal, chemical, and / or physical fluid properties corresponding to one or more concentric zone categories iii.

[0222] In some embodiments, R40 may be surrounded by i1(137) comprising a molten salt mixture using hydroxides, carbonates, nitrites, nitrates, phosphates, and / or other salts. In some embodiments, i1(137) comprises additional reactants / reagents selected from a protective reagent / reactant source (350). In some embodiments, i1(137) comprises a mixture of hydroxides, carbonates, nitrites, nitrates, phosphates, and / or other salts, the mixture comprising a eutectic composition and / or a molten salt mixture. In some embodiments, i1(137) comprises a mixture of hydroxides, carbonates, nitrites, nitrates, phosphates, and / or other salts, the mixture comprising a eutectic and / or molten salt mixture (i.e., molten salt oxidation) containing an oxidizing agent. In some embodiments, i1(137) comprises a mixture of hydroxides, carbonates, nitrites, nitrates, phosphates, and / or other salts, the mixture comprising a eutectic and / or molten salt mixture (i.e., molten salt reduction) containing a reducing agent. In the case of waste supplies with high concentrations of inorganic compounds (e.g., type I or type II salts) that may precipitate under alkaline conditions of R beyond the equilibrium solubility limit, i1(137) may function to maintain the solubility of the various inorganic compounds and prevent the formation of solid deposits along the length of the reactor by influencing the equilibrium solubility limit. Furthermore, combinations of hydroxides, carbonates, nitrites / nitrates, phosphates, and other salts may generate superoxide radicals, which, if diffused within the concentric protection zone, may promote the decomposition of organic compounds.

[0223] In some embodiments, i1(137) may be surrounded by i2(138) which contains a mixture 350 containing at least subcritical water. In some embodiments, i2(138) contains additional reactants / reagents selected from the protective reagent / reactant source 350. In some embodiments, i2(138) contains pH adjusting reagents that raise the pH within i2(138) to >8, >9, or >10. In some embodiments, a porous liner separates i1(137) and i2(138). In some embodiments, i2(138) is maintained at a temperature of <374°C, <350°C, <300°C, <250°C, or <200°C.

[0224] In some embodiments, i2(138) may be surrounded by i3(139) containing a fluid having low thermal conductivity. In some embodiments, i3(139) contains a reactant / reagent selected from a protective reagent / reactant source 350. In some embodiments, a solid liner separates i2(138) and i3(139). In some embodiments, i3 is maintained at a temperature of <200°C.

[0225] In some embodiments, one or more of the reactor protective fluid reagents ix(137)(138)(139) are maintained at temperatures of <374°C, <350°C, <300°C, <250°C, <200°C, <150°C, and / or <100°C. In some embodiments, one or more of the reactor protective fluid reagents ix(137)(138)(139) are maintained for residence times of >2 seconds, >10 seconds, >30 seconds, >60 seconds, >2 minutes, >5 minutes, >7 minutes, >10 minutes, >15 minutes, >20 minutes, >25 minutes, >30 minutes, >35 minutes, >45 minutes, >60 minutes, >120 minutes, >180 minutes, >300 minutes, >600 minutes, >1,200 minutes, >1,800 minutes, or >2,400 minutes. It should be understood that the regeneration options for each concentric protection zone (ix)(137)(138)(139) may depend on their thermal, physical, and / or chemical properties as they flow out of the reactor. Section 5 General

[0226] The terms “reactor,” “hydrothermal reactor,” “modular reactor,” “modular hydrothermal reactor,” “modular regenerative hydrothermal reactor,” “downflow film reactor,” “FFR,” “modular film forming reactor,” “MFR,” “MFFR,” “multilayer film forming reactor,” and “modular downflow film reactor” may be used interchangeably in this specification.

[0227] The terms “bleed,” “bleeded,” or “fluid bleeding” are used to describe the removal and / or transfer of a fluid from one location to another, and / or as part of a regeneration process.

[0228] The terms “injection / bleeding ring,” “injection ring,” “bleeding ring,” “modular film-forming injection ring,” “bleed / injection ring,” “injection and bleeding ring,” “bleed and injection ring,” or “ring” may be used interchangeably in this specification.

[0229] The terms “central reaction zone,” “R,” and “reaction zone” may be used interchangeably in this specification.

[0230] The terms “liquid film formation zone,” “concentric protective zone,” “protective zone,” “ix,” “iii,” “ii,” “i,” “concentric zone,” “fluid barrier,” “flowing liquid film,” “protective fluid barrier,” “barrier,” or “fluid barrier” may be used interchangeably in this specification.

[0231] The terms "protective reagent / reactant" or "protective fluid" refer to the fluid used to constitute all or part of the "concentric protective zone."

[0232] The term "primary injector" refers to an injector that injects reactants into the central reaction zone. The term "primary injector" also includes injectors that inject reactants into the central reaction zone in both the "radial direction" and the "longitudinal direction".

[0233] The term "spent liquid film" refers to a liquid film that has been injected into a reactor, maintained for an appropriate residence time, and then discharged / bled from the reactor. The term "spent" means that the film has achieved its intended purpose in that application and is transported to a regeneration process for reactivation.

[0234] The terms “longitudinal direction” and “axial direction” may be used interchangeably in this specification.

[0235] The terms “tubular shell” and “pressure vessel” may be used interchangeably in this specification.

[0236] It should be understood that the embodiments of the present invention can be modified, altered, and changed in various ways, as well as in their applications, without departing from the scope of the present invention. It should also be understood that the present invention is not limited by any particular embodiment, description, or illustration, or any combination of components or processes disclosed herein. The embodiments have been selected and described to best illustrate the principles of the present invention and its practical applications, thereby enabling those skilled in the art to best utilize the present invention and its various embodiments with various modifications suitable for specific intended applications. While the accompanying drawings are mentioned, it should be noted that these drawings are illustrative and do not limit the scope of the present invention. The scope of the present invention is intended to be defined by the appended claims and their equivalents.

Claims

1. A modular hydrothermal reactor, a. A cylindrical shell having open internal and external cylindrical walls, b. A first injection ring device disposed at one end of the cylindrical shell, i. A first annular body having a central axis, an open internal region, an annular upper surface, an annular lower surface, and an internal cylindrical wall facing the internal region, wherein the internal cylindrical wall has at least one first plurality of openings arranged radially around the central axis, ii. At least one first fluid input port on the outer surface of the first body, iii. At least one first manifold inside the first body that provides fluid communication between the at least one first fluid input port and the at least one first plurality of internal openings, iv. At least one second plurality of openings arranged circumferentially on the annular lower surface of the first annular body, v. At least one second fluid input port on the outer surface of the first body, vi. At least one second manifold inside the first body that provides fluid communication between the at least one second input port and the at least one second plurality of openings on the annular lower surface, A first injection ring device including, c. A second injection ring device located at the other end of the cylindrical shell, i. A second annular body having a second central axis aligned with the first axis, a second open internal region, a second annular upper surface, a second annular lower surface, and a second internal cylindrical wall, wherein the second internal cylindrical wall has at least one third plurality of openings arranged radially around the central axis, ii. At least one third fluid input port on the outer surface of the second body, iii. At least one third manifold inside the second body that provides fluid communication between the at least one third fluid input port and the at least one third plurality of internal openings, iv. At least one fourth plurality of openings arranged circumferentially on the annular upper surface of the second annular body, v. At least one fourth fluid input port on the outer surface of the second body, vi. At least one fourth manifold inside the second body, providing fluid communication between the at least one fourth input port and the at least one fourth plurality of openings on the annular upper surface of the second body, A second injection ring device including, A modular hydrothermal reactor equipped with the following features.

2. a. At least one seventh plurality of openings (112a) is positioned separately from the first plurality of openings and is arranged radially around the central axis, b. At least one seventh fluid input port on the outer surface of the first body, c. At least one first manifold inside the first body that provides fluid communication between the at least one first fluid input port and the at least one first plurality of internal openings, The reactor according to claim 1, further comprising:

3. a. A fifth set of openings arranged circumferentially on the annular lower surface of the annular body and coaxially with the second set of openings, b. A fifth fluid input port on the outer surface of the main body, c. A fifth manifold inside the annular body that provides fluid communication between the fifth input port and the fifth plurality of openings on the annular lower surface, The reactor according to claim 1, further comprising:

4. a. A sixth plurality of openings arranged circumferentially on the annular upper surface of the annular body and coaxially with the fourth plurality of openings, b. The sixth fluid output port on the outer surface of the main body, c. A sixth manifold inside the annular body that provides fluid communication between the sixth fluid output port and the sixth plurality of openings on the annular upper surface, The reactor according to claim 1, further comprising:

5. The reactor according to claim 1, wherein the first injection ring and the second injection ring are connected to at least one liner.

6. The reactor according to claim 1, further comprising a pressurized supply unit for supplying a fluid to be processed into the interior of the cylindrical shell, wherein the cylindrical shell has an inlet and an outlet so that the fluid flows through the inside of the cylindrical shell.

7. The reactor according to claim 1, further comprising at least one sensor selected from the group consisting of temperature, cation conductivity, conductivity, pH, ORP, TOC, DO, COD, flow rate, fluid level, chemical species concentration, pressure, and combinations thereof.

8. An injection ring device for use with a modular hydrothermal reactor, a. An annular body having a central axis, an open internal region, an annular upper surface, an annular lower surface, and an internal cylindrical wall facing the internal region, wherein the internal cylindrical wall has at least one first plurality of openings arranged radially around the central axis, b. At least one first fluid input port on the outer surface of the main body, c. A first fluid manifold inside the main body that provides fluid communication between the first fluid input port and the first plurality of internal openings, d. At least one second plurality of openings arranged circumferentially on the annular lower surface of the annular body, e. At least one second fluid input port on the outer surface of the main body, f. At least one second manifold inside the annular body that provides fluid communication between the at least one second input port and the at least one second plurality of openings on the annular lower surface, g. At least one third plurality of openings arranged circumferentially on the annular upper surface of the annular body, h. At least one third fluid output port on the outer surface of the annular body, i. At least one third manifold inside the annular body that provides fluid communication between the at least one third output port and the at least one third plurality of openings on the annular upper surface of the annular body, An injection ring device equipped with the following features.

9. a. A fourth plurality of openings arranged radially around the central axis and positioned away from at least one of the first plurality of openings, b. The fourth fluid input port on the outer surface of the main body, c. A fourth manifold inside the main body that provides fluid communication between the fourth fluid input port and the fourth plurality of internal openings, The injection ring according to claim 8, further comprising:

10. a. A fifth set of openings arranged circumferentially on the annular lower surface of the annular body and coaxially with the second set of openings, b. A fifth fluid input port on the outer surface of the main body, c. A fifth manifold inside the annular body that provides fluid communication between the fifth input port and the fifth plurality of openings on the annular lower surface, The injection ring according to claim 8, further comprising:

11. a. A sixth set of openings arranged circumferentially on the annular upper surface of the annular body and coaxially with the third set of openings, b. The sixth fluid output port on the outer surface of the main body, c. A sixth manifold inside the annular body that provides fluid communication between the sixth output port and the sixth plurality of openings on the annular upper surface, The injection ring according to claim 8, further comprising:

12. A method for controlling a chemical reaction and protecting the inner wall of a cylindrical chemical reactor containing the chemical reaction with a protective fluid barrier, a. A step of initiating a chemical reaction by introducing at least one reagent or reactant at the first end of the reactor, wherein the at least one reagent or reactant is introduced radially inward in the circumferential direction toward the central axis of the cylindrical reactor and moves along the length of the reactor toward the opposite end to form a central reaction zone. b. A step of forming at least one concentric protective zone by injecting at least one second reagent or reactant circumferentially around the central reaction zone at the first end of the reactor, so that the at least one second reagent or reactant moves coaxially around the central reaction zone along the length of the reactor to the opposite end of the reactor, thereby creating a coaxial protective fluid barrier around the central reaction zone and forming at least one concentric protective zone; A method that includes this.

13. The method according to claim 12, further comprising the additional step of regenerating the protective fluid barrier by bleeding off one selected from the group consisting of reagents, reactants, reaction by-products, and combinations thereof from at least one concentric protective zone, modifying the bled-off one, and returning at least a portion of the modified fluid to the reactor and recirculating it circumferentially around the central reaction zone.

14. The method according to claim 12, further comprising the additional step of injecting at least one third reagent or reactant circumferentially around the first protective fluid barrier at the first end of the reactor to generate a second coaxial protective fluid barrier around the first coaxial protective fluid barrier, and forming at least one second concentric protective zone by causing the at least one third reagent or reactant to move coaxially around the first protective fluid barrier along the length of the reactor to the opposite end of the reactor.

15. The method according to claim 12, further comprising the additional step of bleeding off at least one of the group consisting of reagents, reactants, reaction by-products, and combinations thereof from one of the central reaction zone, the concentric protection zone, or both thereof.

16. The method according to claim 12, wherein the chemical reaction includes supercritical water, the temperature of the central reaction zone is at least 374°C, and the pressure is at least 22.1 MPa.

17. The method according to claim 12, wherein the chemical reaction includes an organic halogen compound.

18. The method according to claim 12, wherein the chemical reaction includes an inorganic compound.

19. The method according to claim 12, wherein the chemical reaction comprises supercritical water oxidation and one selected from the group consisting of an organic compound, an oxidizing agent, supercritical water, and combinations thereof.

20. The method according to claim 12, wherein the at least one concentric protective zone includes one selected from the group consisting of supercritical water, subcritical water, an oxidizing agent, nitrogen, carbon dioxide, and combinations thereof.

21. The method according to claim 12, wherein the at least one concentric protective zone includes one of the following: a reaction initiator that activates the chemical reaction or increases its reaction rate, or a reaction inhibitor that inactivates the chemical reaction or decreases its reaction rate.

22. The method according to claim 12, wherein the at least one concentric protective zone comprises a eutectic or molten salt mixture and one selected from the group consisting of hydroxides, carbonates, nitrates, nitrites, phosphates, inorganic compounds present in the central reaction zone, oxidizing agents, reducing agents, and combinations thereof.

23. The method according to claim 12, wherein the radial injection into the central reaction zone further comprises overfire or decay, and the at least one reagent or reactant further comprises one selected from the group consisting of carbon dioxide, air, nitrogen, chemical inhibitors, chemical initiators, oxidizing agents, and combinations thereof.

24. The method according to claim 13, comprising the step of modifying the protective fluid barrier using one selected from the group consisting of thermal control, pH adjustment, chemical precipitation, ORP adjustment, pressure swing adsorption, sedimentation, centrifugal sedimentation, filtration, ion exchange, liquid-liquid extraction, solid-liquid extraction, oxidation, molten salt oxidation, reduction, adsorption, stripping, chemical scavenging, catalyst regeneration, humidity control, crystallization, and combinations thereof.

25. The method according to claim 24, further comprising an additional step of recovering and removing reaction by-products.

26. The method according to claim 24, further comprising an additional step of recirculating reaction byproducts.

27. The method according to claim 26, further comprising an additional step of removing at least partially reaction byproducts.

28. The method according to claim 24, further comprising the additional step of injecting a supplemental reagent.

29. The method according to claim 12, further comprising the additional step of cleaning the cylindrical shell.

30. The method according to claim 12, wherein the at least one concentric protection zone contains a fluid having a thermal conductivity of less than 1 W / (m*K).

31. The method according to claim 12, wherein the reactor is operated using at least one hydrothermal flame.

32. The method according to claim 12, further comprising the steps of monitoring temperature, cation conductivity, conductivity, pH, ORP, TOC, DO, COD, flow rate, fluid level, chemical species concentration, pressure, operating parameters of the relevant chemical reaction, and combinations thereof by a sensor device coupled to an injection or discharge position, and sending feedback to a control system selected from the group consisting of PLC, DCS, SCADA, machine learning, AI, and combinations thereof.

33. The method according to claim 32, further comprising the additional step of operating the injection ring device in fluid communication with the control system by controlling one selected from the group of injection of at least one concentric protection zone, bleeding of at least one concentric protection zone, input flow rate of reactant, and output flow rate of reactant.

34. The modular hydrothermal reactor according to claim 1, wherein the first injection ring device is coupled to a liner.

35. The modular hydrothermal reactor according to claim 1, wherein the first injection ring device comprises a divided ring section that defines a plurality of fluid manifold layers joined together.

36. The modular hydrothermal reactor according to claim 1, wherein the first injection ring device is positioned between two cylindrical shell segments and fixed by a clamp connection or a flange connection.

37. The modular hydrothermal reactor according to claim 1, wherein the first injection ring device is disposed between a cylindrical shell segment and a cylindrical shell blind flange and clamp connection.

38. The modular hydrothermal reactor according to claim 37, further comprising an injection port for longitudinal injection, coupled to the first injection ring device or the blind flange and clamp connection.

39. An injection ring device for use with a modular hydrothermal reactor, a. An annular body having a central axis, an open internal region, an annular upper surface, an annular lower surface, and an internal cylindrical wall facing the internal region, wherein the internal cylindrical wall has at least one first plurality of openings arranged radially around the central axis, b. At least one first fluid input port on the outer surface of the main body, c. A first manifold inside the main body that provides fluid communication between the first fluid input port and the first plurality of internal openings, d. At least one second plurality of openings arranged circumferentially on the annular lower surface of the annular body, e. At least one second fluid input port on the outer surface of the main body, f. At least one second manifold inside the annular body that provides fluid communication between the at least one second input port and the at least one second plurality of openings on the annular lower surface, An injection ring device equipped with the following features.

40. a. A third plurality of openings arranged circumferentially on the annular lower surface of the annular body and coaxially with the second plurality of openings, b. The third fluid input port on the outer surface of the main body, c. A third manifold inside the annular body that provides fluid communication between the third input port and the third plurality of openings on the annular lower surface, The injection ring according to claim 39, further comprising:

41. An injection ring device for use with a modular hydrothermal reactor, a. An annular body having a central axis, an open internal region, an annular upper surface, an annular lower surface, and an internal cylindrical wall facing the internal region, wherein the internal cylindrical wall has at least one first plurality of openings arranged radially around the central axis, b. At least one first fluid input port on the outer surface of the main body, c. A first fluid manifold inside the main body that provides fluid communication between the first fluid input port and the first plurality of internal openings, j. At least one second plurality of openings arranged circumferentially on the annular upper surface of the annular body, k. At least one second fluid output port on the outer surface of the annular body, l. At least one second manifold inside the annular body, which provides fluid communication between the at least one second output port and the at least one second plurality of openings on the annular upper surface of the annular body, An injection ring device equipped with the following features.

42. a. A third plurality of openings arranged circumferentially on the annular upper surface of the annular body and coaxially with the second plurality of openings, b. The third fluid output port on the outer surface of the main body, c. A third manifold inside the annular body that provides fluid communication between the third output port and the third plurality of openings on the annular upper surface, The injection ring according to claim 41, further comprising:

43. The reactor according to claim 7, wherein the arrangement of the sensors is selected from the group consisting of physically arranged inside the reactor, coupled to an input port, coupled to an output port, and combinations thereof.

44. The method according to claim 12, wherein the temperature of the central reaction zone is at least 100°C and the pressure is at least 1 MPa.

45. The method according to claim 44, wherein the central reaction zone includes a reaction under reducing conditions.

46. The method according to claim 44, wherein the central reaction zone includes a reaction under oxidative conditions.

47. The method according to claim 44, wherein the central reaction zone includes a reaction at a pH greater than 9.

48. The method according to claim 12, wherein the central reaction zone includes chloride, sulfate, silica, calcium, magnesium, iron, sodium, manganese, potassium, hydrogen sulfide, bicarbonate, carbonate, and combinations thereof.

49. The method according to claim 12, wherein the chemical reaction includes PFAS.